Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1050.Time spend outdoors in summer,45303,0.0375892656602396,0.0343478636250551,-0.0297325470448684,0.104911078365348,0.273805452851061
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1060.Time spent outdoors in winter,42133,-0.0184134602012131,0.0393502415602058,-0.0955399336592166,0.0587130132567903,0.639834934560732
CCND2,G1/S-specific cyclin-D2,Physical activities,X1070.Time spent watching television (TV),46660,-0.0354452559590529,0.0352164296881944,-0.104469458147914,0.0335789462298082,0.314187177563477
CCND2,G1/S-specific cyclin-D2,Physical activities,X1080.Time spent using computer,42168,-0.106370780174847,0.0372592032459758,-0.17939881853696,-0.0333427418127344,0.00431022578165065
CCND2,G1/S-specific cyclin-D2,Physical activities,X1090.Time spent driving,39899,-0.0627430412312135,0.0411347437125126,-0.143367138907738,0.0178810564453113,0.127203448859799
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1160.Sleep duration,47949,-0.0188759810202437,0.0318032009174882,-0.0812102548185205,0.0434582927780332,0.552835860866695
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32513,0.0022047016425373,0.0140123019352154,-0.0252594101504848,0.0296688134355594,0.874980497453179
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32513,0.00329190010645989,0.0125198618025547,-0.0212470290265473,0.027830829239467,0.792607999438669
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32513,0.00387751539024065,0.014756594579573,-0.0250454099857224,0.0328004407662037,0.792738490745238
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32513,0.0220300017434995,0.0149931833316879,-0.0073566375866087,0.0514166410736077,0.141781103969428
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32513,0.000957042070057222,0.0152167527458143,-0.0288677933117388,0.0307818774518533,0.949852491799032
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32513,0.0125406999020413,0.0293632630571477,-0.0450112956899682,0.0700926954940507,0.669326574886798
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32513,-0.0196390999849609,0.0286097209039066,-0.0757141529566179,0.0364359529866961,0.492450074099417
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32513,0.00206335466441831,0.0226399653412503,-0.0423109774044322,0.0464376867332688,0.927385431146445
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32513,-0.0139903503950431,0.016306406344405,-0.0459509068300769,0.0179702060399908,0.390936469669904
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32513,0.00797537619241976,0.0112326135771721,-0.0140405464188375,0.029991298803677,0.477712498552929
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32513,0.00320627609605316,0.0155964600428499,-0.0273627855879327,0.033775337780039,0.837126404485416
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32513,0.00396488984286302,0.00954543888749694,-0.014744170376631,0.022673950062357,0.6778820518099
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32513,-0.0238086480653671,0.0118788014563643,-0.0470910989198412,-0.000526197210893063,0.0450716275077432
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32513,-0.0108115713938287,0.0169596413185399,-0.044052468378167,0.0224293255905095,0.523824992525504
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32513,-0.0102346008234047,0.0159973801411317,-0.0415894659000227,0.0211202642532134,0.522342071076678
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32513,0.00338333698482875,0.0223386637566788,-0.0404004439782616,0.0471671179479191,0.879619372033943
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32513,-0.0116568611445615,0.0210676916821816,-0.0529495368416375,0.0296358145525146,0.580069857678382
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32513,0.00892582298174913,0.0126968617826215,-0.0159600261121891,0.0338116720756874,0.482079528522093
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32513,-0.00390830199928274,0.0117869775717946,-0.0270107780400002,0.0191941740414347,0.740216582692869
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32513,0.0128029537529653,0.0157061591777005,-0.0179811182353276,0.0435870257412583,0.41500769109834
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120040.Fatigue severity over the past week,32519,-0.122792533110518,0.0554322079199931,-0.231439660633705,-0.0141454055873319,0.0267752795953914
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32517,-0.075409077667787,0.055895386541408,-0.184964035288947,0.0341458799533727,0.17733921744358
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32516,0.0392438502887114,0.0598558221235806,-0.0780735610735065,0.156561261650929,0.512074716080828
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120098.Mobility problems today,32522,-0.0583768487099091,0.0658076706909349,-0.187359883264142,0.0706061858443233,0.375060802104606
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120099.Self-care problems today,32522,0.0135935274353975,0.103926285938496,-0.190101993004055,0.21728904787485,0.895937018704075
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120100.Problems doing usual activities,32522,-0.0089753651710903,0.0627154550989727,-0.131897657165077,0.113946926822896,0.886204912330517
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120101.Pain or discomfort today,32522,0.00236322090473642,0.0559992762603878,-0.107395360565624,0.112121802375097,0.966339574603127
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120102.Anxiety or depression today,32522,0.0229873293675045,0.0657496914264704,-0.105882065828377,0.151856724563386,0.726633913157618
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120103.Scale to indicate how health is today,32485,0.00147368635737312,0.00411261577466051,-0.00658704056096148,0.00953441327570772,0.720103466602928
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32499,0.0387101975720461,0.0681422972170184,-0.0948487049733098,0.172269100117402,0.569997285159413
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32476,-0.0165177820146451,0.0683224336741932,-0.150429752016064,0.117394187986774,0.808970608113163
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32506,-0.0419534288891611,0.0551969572930033,-0.150139465183447,0.0662326074051253,0.447236323128211
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32506,-0.0156431028114196,0.056782596868356,-0.126936992673397,0.0956507870505581,0.782945994634897
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32510,0.0698558983713156,0.0690598698450366,-0.0655014465249562,0.205213243267587,0.31179481481894
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32482,0.0586335129547831,0.0718622275193502,-0.0822164529831434,0.19948347889271,0.414572612901002
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32505,0.0484551293426363,0.0742123101260567,-0.0970009985044347,0.193911257189707,0.513822781371407
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32496,-0.0521315118302655,0.108390889033335,-0.264577654335601,0.16031463067507,0.630559128160229
CCND2,G1/S-specific cyclin-D2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32463,0.0950421426071015,0.149190528355377,-0.197371292969437,0.38745557818364,0.524109102238434
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30514,-0.0319633365645158,0.0741675667676417,-0.177331767429094,0.113405094300062,0.666511979631367
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45911,-0.0272822192843219,0.0777129338448474,-0.179599569620223,0.125035131051579,0.725543724839259
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44313,-0.0580683419595298,0.0501054766937074,-0.156275076279196,0.0401383923601367,0.246501892947455
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1289.Cooked vegetable intake,47482,-0.0434058238245645,0.0330445579305103,-0.108173157368365,0.0213615097192357,0.18900929535498
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47054,-0.000479700047743478,0.0360768682310017,-0.0711903617805067,0.0702309616850198,0.98939127012158
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1309.Fresh fruit intake,47530,0.0455876089103697,0.0343286426869941,-0.0216965307561388,0.112871748576878,0.184199214979919
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1319.Dried fruit intake,46065,0.061941340100267,0.0346399016521108,-0.00595286713787024,0.129835547338404,0.0737658148863455
CCND2,G1/S-specific cyclin-D2,Health and medical history,X134.Number of self-reported cancers,48202,0.0560158798946559,0.057221800798993,-0.0561388496713704,0.168170609460682,0.327626764535293
CCND2,G1/S-specific cyclin-D2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48202,-0.0750453848700175,0.0329490766375839,-0.139625575079682,-0.0104651946603531,0.0227582396950961
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X136.Number of operations, self-reported",48202,-0.0675124587078735,0.0336203210992426,-0.133408288062389,-0.00161662935335799,0.0446455744526578
CCND2,G1/S-specific cyclin-D2,Health and medical history,X137.Number of treatments or medications taken,48202,-0.0483135336909028,0.032350862186323,-0.111721223576096,0.0150941561942902,0.135339683542727
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1438.Bread intake,47384,0.00411019257334297,0.00272145484035608,-0.00122385891375495,0.00944424406044089,0.130982607237519
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1458.Cereal intake,47008,0.0495274272706555,0.0328533736893006,-0.0148651851603737,0.113920039701685,0.131689015068683
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1488.Tea intake,47401,0.00191651701703143,0.00253074357718112,-0.00304374039424358,0.00687677442830643,0.448881498484249
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1498.Coffee intake,46343,0.0361986704279088,0.0330101230481888,-0.0285011707465411,0.100898511602359,0.272831404802313
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X1528.Water intake,46725,-0.020573102239279,0.0339113917549445,-0.0870394300789701,0.0458932256004122,0.544074588214422
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1568.Average weekly red wine intake,38935,-0.0803489645300548,0.0407526828058078,-0.160224222829438,-0.000473706230671583,0.0486715574223123
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,38928,0.0134139181802424,0.0408827070712267,-0.0667161876793619,0.0935440240398466,0.742835214780554
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1588.Average weekly beer plus cider intake,38955,0.0236064330419704,0.0517691992130733,-0.0778611974156533,0.125074063499594,0.648401276208119
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1598.Average weekly spirits intake,38890,0.00826450546473557,0.0456851310757603,-0.0812783514437547,0.0978073623732258,0.856447487044853
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1608.Average weekly fortified wine intake,38957,0.0554881256392871,0.0701253917138778,-0.0819576421199134,0.192933893398488,0.428799332205274
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X1737.Childhood sunburn occasions,42513,-0.0466372509188313,0.039629912433531,-0.124311879288552,0.0310373774508894,0.23928309600576
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1807.Father's age at death,41886,-0.000344527532486065,0.00289915254404596,-0.00602686651881615,0.00533781145384402,0.905405606461243
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1845.Mother's age,33654,-0.0012092670035804,0.00680624520812973,-0.0145495076115147,0.0121309736043539,0.858985893978152
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1873.Number of full brothers,47753,0.0289813857796255,0.0319661209161431,-0.033672211216015,0.091634982775266,0.36461283429646
CCND2,G1/S-specific cyclin-D2,Health and medical history,X1883.Number of full sisters,47757,-0.0330550410717144,0.0320109808034276,-0.0957965634464325,0.0296864813030038,0.301794498040899
CCND2,G1/S-specific cyclin-D2,Physical measures,X20015.Sitting height,48036,-0.00375816591608705,0.00334563070357576,-0.0103156020950955,0.00279927026292144,0.261319133861885
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20016.Fluid intelligence score,32173,-0.0920086601168162,0.0542735281459404,-0.198384775282859,0.014367455049227,0.0900632826631045
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20018.Prospective memory result,32463,0.0248019677226254,0.0715923903679424,-0.115519117398542,0.165123052843793,0.729026415855063
CCND2,G1/S-specific cyclin-D2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32059,0.000535021043938375,0.00446962978479913,-0.00822545333426793,0.00929549542214467,0.904722834367094
CCND2,G1/S-specific cyclin-D2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32044,0.000536440061533248,0.00446248168906495,-0.00821002404903406,0.00928290417210055,0.904319065301888
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20023.Mean time to correctly identify matches,47926,0.00117125719849339,0.00275428567914958,-0.00422714273263978,0.00656965712962656,0.670659074058011
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45440,-0.00521365997202671,0.00562492883686074,-0.0162385204922738,0.00581120054822034,0.353997106660611
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45075,0.00476926796074262,0.0122078071847804,-0.019158034121427,0.0286965700429123,0.69604255186454
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45047,-0.00521814225325304,0.0167028278847421,-0.0379556849073475,0.0275194004008414,0.754731577928532
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45064,-0.00353416384724629,0.0133039268393509,-0.0296098604523741,0.0225415327578815,0.790512838862231
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45069,0.0162540094027564,0.00999975293327061,-0.00334550634645402,0.0358535251519668,0.104083889173465
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#2.Illnesses of father_Stroke,45203,0.00408396973875101,0.00730736097375642,-0.0102384577698116,0.0184063972473136,0.576246676954798
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45152,-0.00762314393801207,0.00920061394827069,-0.0256563472766226,0.0104100594005985,0.407370166501123
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45072,-0.0139939944101607,0.0117557789359567,-0.0370353211246357,0.00904733230431439,0.233905752294082
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45212,-0.00023406337205369,0.00826103995676535,-0.0164257016873138,0.0159575749432064,0.977396512109625
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45251,0.00881100528844047,0.00627705031307178,-0.00349201332518022,0.0211140239020612,0.160427414910288
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45140,0.0099652277147289,0.0087423427062495,-0.00716976398952012,0.0271002194189779,0.254349204034478
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46589,-0.00265983990582849,0.00623887240135471,-0.0148880298124837,0.00956835000082674,0.669869042881493
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46477,-0.0145676511700791,0.00912698964018988,-0.0324565508648513,0.00332124852469306,0.110479274609593
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46420,-0.0313055663552213,0.0197925407349568,-0.0700989461957366,0.00748781348529391,0.113735876786473
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46452,-0.00371431040930132,0.0098330944133648,-0.0229871754594963,0.0155585546408937,0.705630618175653
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46537,-0.00229425686180706,0.00717392368255886,-0.0163551472796224,0.0117666335560083,0.749119161240033
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46432,-0.012441474018358,0.0132809492552223,-0.0384721345585938,0.0135891865218777,0.348876357273324
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46432,0.00882256819061271,0.0117740793824257,-0.0142546273989416,0.0318997637801671,0.453671606147359
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46457,0.0112720808413075,0.00934239820117481,-0.00703901963299513,0.0295831813156101,0.227618038781883
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46476,0.00463792663133741,0.0105055893250388,-0.0159530284457386,0.0252288817084134,0.658875448202009
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46622,0.000766924481477395,0.00542879352093953,-0.00987351081956409,0.0114073597825189,0.887658103569274
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46492,0.00130803024527238,0.00852868315269627,-0.0154081887340123,0.0180242492245571,0.878109189819481
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43519,-0.00347278357447265,0.00891547152511605,-0.0209471077637001,0.0140015406147548,0.696893454606438
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43393,-0.0388212077732389,0.0350739253789361,-0.107566101515954,0.0299236859694758,0.268377361984745
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43391,-0.0367246945125701,0.0362636044635281,-0.107801359261085,0.034351970235945,0.311209270695582
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43447,6.63287716263907e-05,0.0099539058810141,-0.0194433267551612,0.019575984298414,0.994683331824828
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43404,0.0249204733757823,0.0209624177610628,-0.0161658654359007,0.0660068121874653,0.234526680255745
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43418,0.0015475534652958,0.0150207946286725,-0.0278932040069022,0.0309883109374939,0.917942311299652
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43399,-0.0167505357023043,0.0183712347134874,-0.0527581557407396,0.019257084336131,0.361895816753182
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43397,-0.0121072629208298,0.01808880088139,-0.0475613126483543,0.0233467868066946,0.503297175729798
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43414,-0.0146469445585417,0.013020879036272,-0.0401678674696348,0.0108739783525514,0.26065353590927
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43420,0.00591485371284262,0.0158989382130224,-0.0252470651846812,0.0370767726103665,0.709875993027552
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43580,-0.00400203819183366,0.00657855132986674,-0.0168959987983725,0.00889192241470515,0.54296495886307
CCND2,G1/S-specific cyclin-D2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43476,-0.0158163597489556,0.00943273263693371,-0.0343045157173457,0.00267179621943447,0.093607283877979
CCND2,G1/S-specific cyclin-D2,Mental health,X20127.Neuroticism score,43102,0.0612363433458206,0.0334985680226145,-0.00442084997850384,0.126893536670145,0.0675612221214728
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32173,-0.0812435239306831,0.0548476214081111,-0.188744861890581,0.0262578140292146,0.138578477467897
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20161.Pack years of smoking,30837,-0.00129495916590372,0.00552596640265306,-0.0121258533151037,0.00953593498329629,0.814727957388738
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30837,-0.00138262540848483,0.00544527257344979,-0.0120553596524464,0.00929010883547677,0.799570958081015
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20191.Fluid intelligence score,30358,0.0479196933614411,0.0595650681944749,-0.0688278402997298,0.164667227022612,0.42114463271139
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30358,0.0398306261881233,0.0611853356700447,-0.0800926317251643,0.159753884101411,0.515082703005719
CCND2,G1/S-specific cyclin-D2,Cognitive function,X20240.Maximum digits remembered correctly,29706,-0.057376554403132,0.0638253036689669,-0.182474149594307,0.0677210407880431,0.368713895759933
CCND2,G1/S-specific cyclin-D2,Physical measures,X20255.Spirometry QC measure,42652,0.0495550397762169,0.0439297228379499,-0.0365472169861649,0.135657296538599,0.259312557649474
CCND2,G1/S-specific cyclin-D2,Eye measures,X20261.avMSE,29682,-0.00454037727744015,0.00513471649859543,-0.0146044216146872,0.00552366705980689,0.376601477061186
CCND2,G1/S-specific cyclin-D2,Eye measures,X20262.Myopia diagnosis,29682,0.0220699616813712,0.0815969110133522,-0.137859983904799,0.181999907267542,0.786805171768208
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20280.Glucose-lactate,37677,0.000930980720747728,0.00352709459431858,-0.00598212468411669,0.00784408612561214,0.79182166332802
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37708,-0.0124984752383146,0.00337054102882331,-0.0191047356548083,-0.00589221482182095,0.000209629573234486
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31899,0.0170890264103568,0.0156188509778506,-0.0135239215062304,0.047701974326944,0.273934112844884
CCND2,G1/S-specific cyclin-D2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31897,0.0187441607744821,0.0293079530562858,-0.0386994272158381,0.0761877487648022,0.522479120068145
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31895,0.016606534880794,0.0373129659713737,-0.0565268784230985,0.0897399481846866,0.656288828684569
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31895,-0.00559550465284811,0.0146685918820867,-0.034345944741738,0.0231549354360417,0.70287164222232
CCND2,G1/S-specific cyclin-D2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31895,0.0211395612736786,0.0289063873896093,-0.0355169580099555,0.0777960805573127,0.464612188626738
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31901,-0.082264063181839,0.0349829557901508,-0.150830656530535,-0.0136974698331433,0.0187214332071081
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31901,-0.00368554179945354,0.0235871413604694,-0.0499163388659736,0.0425452552670665,0.875838497641635
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31901,-0.0023090006742699,0.0259422467935563,-0.0531558043896403,0.0485378030411005,0.929079992289426
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31901,0.00399408374252204,0.041824931929166,-0.0779827828386432,0.0859709503236873,0.923924004895135
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31901,-0.0145252639281228,0.0503520450787977,-0.113215272282566,0.0841647444263207,0.772991833720482
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31901,0.00139863642020769,0.0273081029485855,-0.0521252453590199,0.0549225181994353,0.959154057302154
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31901,-0.0720925332528508,0.0512931376947484,-0.172627083134558,0.0284420166288562,0.159914190956913
CCND2,G1/S-specific cyclin-D2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31901,-0.0476985732093489,0.0354403592847651,-0.117161677407488,0.0217645309887906,0.178381247026595
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31901,-0.0357710547060785,0.0434776585790303,-0.120987265520978,0.0494451561088209,0.410678982900258
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31901,0.00111282099962981,0.0197865069213325,-0.0376687325661819,0.0398943745654415,0.955151003293792
CCND2,G1/S-specific cyclin-D2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31901,-0.0109377610771164,0.0324025283965869,-0.0744467167344266,0.0525711945801939,0.735705148142314
CCND2,G1/S-specific cyclin-D2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31902,0.053857857253039,0.0499779128789383,-0.04409885198968,0.151814566495758,0.281232379951905
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20600.Liking for adding salt to foods,33284,-0.0104732580309478,0.0491130060661687,-0.106734749920638,0.0857882338587428,0.831138335092431
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20601.Liking for aniseed,33284,-0.059438419560088,0.0490778755459488,-0.155631055630148,0.0367542165099717,0.225887922852277
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20602.Liking for apple juice,33284,0.00788979652951168,0.0489155837361659,-0.0879847475933734,0.103764340652397,0.871865439206304
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20603.Liking for apples,33284,0.0476207540598112,0.0503003736205611,-0.0509679782364886,0.146209486356111,0.3438035088756
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20604.Liking for asparagus,33284,0.0147389665554683,0.0506465719231428,-0.0845283144138915,0.114006247524828,0.771045866062427
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20605.Liking for aubergine,33284,-0.029706172757625,0.0491497055481649,-0.126039595632028,0.0666272501167783,0.545592050077494
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20606.Liking for avocados,33284,-0.0441316785469844,0.0507920832871823,-0.143684161789862,0.0554208046958928,0.384942292580053
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20607.Liking for bacon,33284,0.0448153499928628,0.0491102661003138,-0.0514407715637523,0.141071471549478,0.361506587438198
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20608.Liking for baked or steamed fish,33284,0.0306966530658866,0.0501573531765453,-0.0676117591601422,0.129005065291916,0.540548872519966
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20609.Liking for bananas,33284,0.0808452001854301,0.0508592757686815,-0.0188389803211857,0.180529380692046,0.111963950860131
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33284,0.00487113078479442,0.0492507991534075,-0.0916604355558843,0.101402697125473,0.921216260272271
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20611.Liking for beef steak,33284,-0.0749030639939133,0.0492561577526058,-0.171445133189021,0.0216390052011942,0.128374923747179
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20612.Liking for beetroot,33284,0.0477431609552751,0.0504717103443613,-0.051181391319673,0.146667713230223,0.344205586958632
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20613.Liking for bell pepper,33284,-0.0243439270338854,0.0495337907560952,-0.121430156915832,0.0727423028480613,0.623112644688264
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20614.Liking for bicycling,33284,-0.010778377794831,0.0494877595845727,-0.107774386580594,0.0862176309909315,0.827590866732115
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20615.Liking for biscuits,33284,0.0637362872091883,0.0494895253681502,-0.0332631825123861,0.160735756930763,0.197823504017717
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20616.Liking for bitter foods,33284,-0.0273587929880877,0.0495348027783567,-0.124447006433667,0.0697294204574914,0.580746844547844
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20617.Liking for bitter or ale,33284,-0.0138186214107311,0.0510719753276527,-0.11391969305293,0.0862824502314682,0.786726940398457
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20618.Liking for black olives,33284,-0.0153555080348721,0.0494444188052342,-0.112266568893131,0.0815555528233869,0.756141717071665
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20619.Liking for black pepper,33284,0.0421680282306154,0.0496439483599619,-0.0551341105549099,0.139470167016141,0.395676662335103
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20620.Liking for blue cheese,33284,-0.0350653106290355,0.0493266502310651,-0.131745545081923,0.0616149238238521,0.477177623977435
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20621.Liking for bolognese sauce,33284,-0.0558386926895361,0.0494040818762649,-0.152670693167015,0.0409933077879432,0.258403930003031
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20622.Liking for broad beans,33284,0.0358773371764069,0.0493462226448364,-0.0608412592074724,0.132595933560286,0.467212555922516
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20623.Liking for broccoli,33284,0.108802668905809,0.0514140701190412,0.00803109147248834,0.20957424633913,0.0343553766693102
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20624.Liking for brown rice,33284,0.0156352371434904,0.0492957800508425,-0.0809844917561609,0.112254966043142,0.751120661085097
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20625.Liking for brussel sprouts,33284,-0.0403276600201325,0.0499969128721151,-0.138321609249478,0.0576662892092131,0.419916984558321
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20626.Liking for burgers (meat),33284,-0.0281164512067842,0.049263895159924,-0.124673685720235,0.0684407833066668,0.568196274275226
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20627.Liking for burn of spicy foods,33284,-0.0125080535579746,0.0491403525857893,-0.108823144626122,0.0838070375101725,0.799086409559497
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20628.Liking for butter on bread,33284,0.0830256496242996,0.0502847763344092,-0.0155325119911425,0.181583811239742,0.0987518975383255
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20629.Liking for butternut squash,33284,0.0277363628307497,0.0492965035027914,-0.0688847840347215,0.124357509696221,0.5736918830402
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20630.Liking for cabbage,33284,0.0290038549127214,0.050059753562255,-0.0691132620692983,0.127120971894741,0.562344422906552
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20631.Liking for cake,33284,0.125073566504961,0.0493056002675959,0.0284345899804735,0.22171254302945,0.0112073331139608
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20632.Liking for cake icing,33284,0.016572517151376,0.0487432959288567,-0.078964342869183,0.112109377171935,0.733867764916728
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20633.Liking for capers,33284,-0.000423607990926435,0.0489322258898656,-0.096330770735063,0.0954835547532102,0.993092967451062
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20634.Liking for cauliflower,33284,-0.0309050229686105,0.0503632373943466,-0.12961696826153,0.0678069223243089,0.539467411379604
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20635.Liking for cereal or granola bar,33284,0.0673187531578418,0.0491140482886429,-0.0289447814878982,0.163582287803582,0.170515254744588
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20636.Liking for cheesecake,33284,0.0576413788941445,0.0486694326400089,-0.037750709080273,0.153033466868562,0.236308590855526
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20637.Liking for cherries,33284,-0.0490216896699821,0.0534836010180746,-0.153849547665408,0.0558061683254441,0.359390852337977
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20638.Liking for chicken,33284,-0.0103602568449299,0.0524706005915045,-0.113202634004279,0.0924821203144189,0.843480896819322
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20639.Liking for chilli pepper,33284,-0.0505591594204328,0.0491201469130429,-0.146834647369997,0.0457163285291312,0.303368925993116
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20640.Liking for chips or french fries,33284,0.0633527278605499,0.0493630428874377,-0.0333988361988281,0.160104291919928,0.199384271938461
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20641.Liking for cigarette smoking,33284,-0.0506479883794925,0.0825569020661101,-0.212459516429068,0.111163539670083,0.539566970714843
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20642.Liking for cod,33284,-0.00208841441147111,0.0506135854006328,-0.101291041796712,0.0971142129737693,0.967088013249846
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20643.Liking for coffee with sugar,33284,0.000949819159133972,0.0558483403069239,-0.108512927842437,0.110412566160705,0.986431324007579
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20644.Liking for coffee without sugar,33284,0.0268517443776449,0.050382983756625,-0.0718989037853401,0.12560239254063,0.594079785228479
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20645.Liking for coriander,33284,-0.0131493734459655,0.0496105961497718,-0.110386141899518,0.0840873950075871,0.790975817272249
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20646.Liking for corn flakes,33284,0.0606781655430184,0.0490332188902843,-0.0354269434819387,0.156783274567976,0.215937796915377
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20647.Liking for cream,33284,0.0947915499454961,0.0488941155870732,-0.00104091660516732,0.19062401649616,0.0525684123742525
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20648.Liking for croissant,33284,-0.0181037532227302,0.0490088118228461,-0.114161024395509,0.0779535179500482,0.711840011885007
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20649.Liking for cucumber,33284,-0.0222387165212958,0.0498266630494582,-0.119898976098234,0.0754215430556424,0.65537590099969
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20650.Liking for curry,33284,-0.0468648401902862,0.0497094908958851,-0.144295442346221,0.0505657619656486,0.345822073331815
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20651.Liking for dairy products,33284,0.0437915875461166,0.0499817916924833,-0.0541727241711506,0.141755899263384,0.380971903372507
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20652.Liking for dark chocolate,33284,-0.0930740615428633,0.0497924561400911,-0.190667275577442,0.00451915249171533,0.0616225031383257
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33284,-0.0418433788368526,0.0514425364434013,-0.142670750265919,0.0589839925922139,0.416010489206359
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20654.Liking for dried fruit,33284,0.0766735884317405,0.0495445301411065,-0.0204336906448284,0.173780867508309,0.121761919615643
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20655.Liking for eggs,33284,-0.0183465929538437,0.0514519613511464,-0.119192437202091,0.0824992512944032,0.721416924249245
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20656.Liking for exercising alone,33284,0.00984035090423668,0.0491615281385937,-0.086516244247407,0.10619694605588,0.841357208273632
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20657.Liking for exercising with others,33284,0.0726531160896525,0.0489870481865502,-0.0233614983559859,0.168667730535291,0.138081257518755
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33284,0.0377385386983943,0.0503348842303039,-0.0609178343930012,0.13639491178979,0.453425765717736
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20659.Liking for fatty foods,33284,0.0399628773135383,0.0493628837487327,-0.0567883748339778,0.136714129461054,0.418207236988765
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20660.Liking for fresh tomatoes,33284,0.033211203784916,0.0544570648090508,-0.0735246432408236,0.139947050810656,0.541970035317894
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20661.Liking for fried chicken,33284,0.0120361371838425,0.0489310789316428,-0.0838687775221774,0.107941051889862,0.805702322868672
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20662.Liking for fried or battered fish,33284,0.0374877222429191,0.0491952734112293,-0.0589350136430904,0.133910458128929,0.446069164479798
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20663.Liking for fruit,33284,-0.0130927025315759,0.0575352404867135,-0.125861773885534,0.0996763688223826,0.819993819106508
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20664.Liking for garlic,33284,-0.0241363513058101,0.0501392971336116,-0.122409373687689,0.0741366710760688,0.630254185464897
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20665.Liking for gherkins,33284,-0.0512251785825385,0.04895872234155,-0.147184274371977,0.0447339172068996,0.295454343564244
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20666.Liking for globe artichoke,33284,-0.0965290474645519,0.049146970366555,-0.192857109383,-0.000200985546104163,0.0495510627766378
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20667.Liking for goat's cheese,33284,-0.0492370210118361,0.0490861118516972,-0.145445800241163,0.0469717582174904,0.315852485376743
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20668.Liking for going to a cafe,33284,-0.0220980956119415,0.0497139476262687,-0.119537432959428,0.0753412417355452,0.656688456352097
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20669.Liking for going to the gym,33284,0.0140955001844394,0.0492431983200957,-0.0824211685229482,0.110612168891827,0.774699053030034
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20670.Liking for going to the pub,33284,-0.0860923864874872,0.0492669126701727,-0.182655535321026,0.0104707623460512,0.0805908623946917
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20671.Liking for grapefruit,33284,0.0423446749121054,0.0488269163402584,-0.0533560811148009,0.138045430939012,0.385833884600737
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20672.Liking for green olives,33284,-0.0428567048109376,0.0494970977720654,-0.139871016444186,0.0541576068223105,0.386599927525333
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20673.Liking for haddock,33284,0.0154062506887235,0.050405368727552,-0.0833882720172784,0.114200773394725,0.759880627333169
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20674.Liking for ham,33284,-0.0149196669669772,0.0492651163145384,-0.111479294943472,0.0816399610095179,0.762015547765866
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20675.Liking for hard cheese,33284,0.013681705081868,0.0502295200414047,-0.0847681541992853,0.112131564363021,0.785333339298352
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20676.Liking for herring,33284,0.0511320509365892,0.0491501470033174,-0.045202237189913,0.147466339063091,0.298218155413401
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20677.Liking for honey,33284,0.0628506830290528,0.0489761685522781,-0.0331426073334123,0.158843973391518,0.199423801828667
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33284,-0.046858892167948,0.049125593404937,-0.143145055241624,0.0494272709057286,0.340181122476301
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20679.Liking for ice cream,33284,0.0252619136788742,0.0490404217952478,-0.0708573130398114,0.12138114039756,0.606479057721206
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20680.Liking for jam,33284,-0.00885325488573703,0.0489713217933947,-0.104837045600791,0.0871305358293166,0.856540898800154
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20681.Liking for kiwi fruit,33284,-0.0331845291720192,0.0492763549649254,-0.129766184903273,0.0633971265592346,0.500686846027268
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20682.Liking for lager,33284,-0.0457268027987867,0.0496389186866946,-0.143019083424708,0.0515654778271347,0.356977189597106
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20683.Liking for lamb,33284,-0.0506567817853368,0.0498191172910155,-0.148302251675727,0.0469886881050536,0.309269746242978
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20684.Liking for lemons,33284,-0.0360502200014378,0.0494170725446302,-0.132907682188913,0.0608072421860374,0.465709472521101
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20685.Liking for lentils or beans,33284,-0.023230354939684,0.049678939722803,-0.120601076796378,0.07414036691701,0.640075263785052
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20686.Liking for liver,33284,-0.0190154386386334,0.0495458844236072,-0.116125372108904,0.0780944948316368,0.701140002353876
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20687.Liking for mackerel,33284,0.0355638676885283,0.0493659900497707,-0.0611934728090223,0.132321208186079,0.471290248494895
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20688.Liking for marzipan,33284,0.0872977218532814,0.0488890018517082,-0.00852472177606665,0.183120165482629,0.0741933446327185
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20689.Liking for mayonnaise,33284,-0.0507623983059538,0.0492750247509028,-0.147341446817723,0.0458166502058157,0.302951342733983
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20690.Liking for melon,33284,-0.0602765741338961,0.0516655918193334,-0.16154113409979,0.0409879858319974,0.243376147556064
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20691.Liking for milk chocolate,33284,0.0955697439081743,0.0494375995127685,-0.001327951136852,0.192467438953201,0.0532510530470611
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20692.Liking for mushrooms,33284,-0.0458671329949581,0.0509855675758947,-0.145798845443712,0.0540645794537955,0.368352316854865
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20694.Liking for orange juice,33284,0.0430639030725832,0.0490562946696669,-0.0530864344799639,0.13921424062513,0.380050857373236
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20695.Liking for oranges,33284,0.0247226838037785,0.0502026279471317,-0.0736744669725995,0.123119834580157,0.622407887102062
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20696.Liking for pasta,33284,-0.0043960746379201,0.0500215197887505,-0.102438253423871,0.0936461041480309,0.92997113190357
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20697.Liking for pears,33284,0.0204096075352211,0.0507536214112576,-0.0790674904308438,0.119886705501286,0.687597316919048
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20698.Liking for pizza,33284,0.0414825159802318,0.049108631128009,-0.0547704010306659,0.137735432991129,0.398296086112132
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20699.Liking for plain yogurt,33284,0.00655321221134853,0.049918571251238,-0.091287187441078,0.104393611863775,0.895558355842181
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20700.Liking for plums,33284,0.0170869762315234,0.0504753048970154,-0.0818446213666267,0.116018573829674,0.734978278466538
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20701.Liking for pollock,33284,0.0293716142281097,0.0490644636503012,-0.0667947345264807,0.1255379629827,0.549432915560396
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20702.Liking for pork chop,33284,-0.0171666286038202,0.0491588890344912,-0.113518051111423,0.0791847939037826,0.726942238222821
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20703.Liking for porridge,33284,0.0401194503186289,0.0505466458090611,-0.0589519754671309,0.139190876104389,0.427384792187314
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20704.Liking for potato crisps,33284,0.0786962737062051,0.0495155064824386,-0.0183541189993745,0.175746666411785,0.112022678494843
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20705.Liking for potatoes,33284,0.0416491928087033,0.0499535404715403,-0.0562597465155157,0.139558132132922,0.404439610548144
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20706.Liking for prawns,33284,0.013211556062969,0.0502290056344555,-0.0852372949805637,0.111660407106502,0.792536349174026
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20707.Liking for raw carrots,33284,-9.73656657812998e-05,0.0502118367804314,-0.0985125657554268,0.0983178344238643,0.998452868555481
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20708.Liking for red meat,33284,-0.0509230130854464,0.0493048029565851,-0.147560426880353,0.0457144007094604,0.301716199704868
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20709.Liking for red wine,33284,-0.0683575049419171,0.0489561458163511,-0.164311550741965,0.0275965408581311,0.162659063758204
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33284,0.0339104241064596,0.051960345066359,-0.067931852223604,0.135752700436523,0.514017500887128
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20711.Liking for roast chicken,33284,-0.00221510696313326,0.0525206472664248,-0.105155575605326,0.100725361679059,0.966359407635255
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20712.Liking for salad dressing,33284,-0.0249024346767029,0.0487965330068192,-0.120543639370069,0.0707387700166628,0.609831619968568
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20713.Liking for salad leaves,33284,-0.00434895947088073,0.0513658535716566,-0.105026032471328,0.0963281135295662,0.932528567548611
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20714.Liking for salami,33284,-0.0106978252702373,0.0493137852052242,-0.107352844272477,0.085957193732002,0.828264976383581
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20715.Liking for salmon,33284,-0.000707035195515171,0.0528234063857739,-0.104240911711632,0.102826841320602,0.98932102878176
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20716.Liking for salty foods,33284,-0.00994720225780092,0.0487359880737353,-0.105469738882322,0.0855753343667202,0.838277061959479
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20717.Liking for salty pretzels,33284,-0.0183483112913264,0.0494134288989943,-0.115198631933355,0.0785020093507025,0.710406357702496
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20718.Liking for sardines,33284,0.0270863367919656,0.0489728766598592,-0.0689005014613584,0.12307317504529,0.580216797529422
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20719.Liking for sausages (meat),33284,-0.0162100693338624,0.0490141133767946,-0.11227773155238,0.0798575928846549,0.74086197049
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20720.Liking for savoury biscuits,33284,0.000544419324794079,0.049405330768956,-0.0962900289823597,0.0973788676319479,0.991208182045682
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33284,-0.0867745335306493,0.0491978867218184,-0.183202391505413,0.00965332444411482,0.0778026542555857
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20722.Liking for skimmed milk,33284,0.0415768126120112,0.0492023229429238,-0.0548597403561195,0.138013365580142,0.398124110059339
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20723.Liking for smoked fish,33284,-0.00958589496033115,0.049591746691081,-0.10678571847485,0.0876139285541876,0.846731470906362
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20724.Liking for soft cheese,33284,-0.0759612187792277,0.0494081558052211,-0.172801204157461,0.0208787665990056,0.124225697537617
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20725.Liking for soy sauce,33284,-0.0388241806294423,0.0492811590379001,-0.135415252343727,0.0577668910848419,0.430829124638587
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20726.Liking for soya milk,33284,-0.0345182273924764,0.0491844350500431,-0.130919720090561,0.061883265305608,0.482814917541026
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20727.Liking for spicy foods,33284,-0.0119342955351716,0.049322635551863,-0.108606661216823,0.0847380701464798,0.808813786299264
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20728.Liking for spinach,33284,0.00429932192685283,0.0501801024395922,-0.0940536788547478,0.102652322708453,0.931724476154966
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20729.Liking for spirits,33284,-0.127251299292444,0.049043930230886,-0.223377402544981,-0.0311251960399078,0.00948469342209033
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20730.Liking for strawberries,33284,-0.0739481277363397,0.0563093569405647,-0.184314467339847,0.0364182118671671,0.189133681196003
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33284,-0.00151116842565628,0.0511370290828594,-0.101739745428061,0.0987174085767481,0.976425530979798
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20732.Liking for sweet foods,33284,0.0612407216341775,0.0489851757798498,-0.034770222894328,0.157251666162683,0.21126371800729
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20733.Liking for taking the stairs,33284,0.0185665220561218,0.0506425931164466,-0.0806929604521134,0.117826004564357,0.71391224289337
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20734.Liking for tea with sugar,33284,-0.0327188114878238,0.0655824052755871,-0.161260325827975,0.095822702852327,0.617864962953638
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20735.Liking for tea without sugar,33284,0.0511430837310035,0.0526314687182843,-0.0520145949568337,0.154300762418841,0.331216190844352
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20736.Liking for tomato ketchup,33284,-0.079102760626506,0.0488176711139082,-0.174785396009766,0.016579874756754,0.105188244876046
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20737.Liking for tinned tuna,33284,0.0188536879827279,0.0495616271669271,-0.0782871012644491,0.115994477229905,0.703651008108392
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20738.Liking for turnip (white),33284,0.0266652217981684,0.0490168988509801,-0.0694078999497526,0.122738343546089,0.586454814227942
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20739.Liking for vegetables,33284,0.0690643893528606,0.0574349765959337,-0.0435081647751694,0.181636943480891,0.229210023436771
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20740.Liking for vinegar,33284,0.0246264962898494,0.0493023619006468,-0.0720061330354183,0.121259125615117,0.61744012019868
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20741.Liking for watching television,33284,-0.0492825790562977,0.0494179509223776,-0.146141762864158,0.0475766047515625,0.318665345857116
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20742.Liking for whisky,33284,-0.0888048758816776,0.0522344045901143,-0.191184308878302,0.0135745571149465,0.0891431687630877
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20743.Liking for white bread,33284,0.0769917665209436,0.0490405398689855,-0.0191276916222679,0.173111224664155,0.116459894441646
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20744.Liking for white rice,33284,-0.00846057772742422,0.0493789273583591,-0.105243275349808,0.0883221198949597,0.863960481641627
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20745.Liking for white wine,33284,0.0114784189601846,0.0491943330738749,-0.0849424738646103,0.107899311784979,0.815512073520245
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33284,0.0369212909386396,0.049928774302773,-0.0609391066947955,0.134781688572075,0.459635728461101
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20747.Liking for whole milk,33284,0.0966944264649872,0.0489999822464509,0.000654461261943476,0.192734391668031,0.0484861338869669
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20748.Liking for wholemeal bread,33284,0.00721599604506248,0.0520939699119631,-0.0948881849823852,0.10932017707251,0.889833545803465
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X20749.Liking for working up a sweat,33284,0.0570919912447436,0.0495607120377816,-0.0400470043493083,0.154230986838796,0.249368446329209
CCND2,G1/S-specific cyclin-D2,Physical measures,X21001.Body mass index (BMI),48117,0.00131450238505761,0.009682503795367,-0.0176632050538617,0.0202922098239769,0.892011705377681
CCND2,G1/S-specific cyclin-D2,Physical measures,X21002.Weight,48124,-0.00144688200444479,0.0060203659685424,-0.0132467993027879,0.0103530352938983,0.810075561488751
CCND2,G1/S-specific cyclin-D2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32372,-0.00469774947348691,0.00415431953888539,-0.0128402157697023,0.00344471682272846,0.258168967272372
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32801,-0.0403789595023586,0.0520439584122404,-0.14238511799035,0.0616271989856326,0.437852122631949
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32815,-0.129166110446778,0.0546557751320743,-0.236291429705643,-0.022040791187912,0.0181374385534865
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32816,0.0294848149690189,0.054720047490058,-0.0777664781114947,0.136736108049533,0.590018358495896
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21040.Satisfaction with bowel habits,32768,-0.00932262635351326,0.050620421456789,-0.10853865240882,0.0898933997017932,0.85388670669076
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32756,-0.0213910945475932,0.0527621807410496,-0.12480496880005,0.082022779704864,0.685175768760967
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21042.Greatest number of times bowels opened per day,32766,0.028405020721058,0.0543557844098947,-0.0781323167223357,0.134942358164452,0.601283369710564
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21043.Least number of times bowels opened per week,32686,0.100440546868794,0.0540764936016271,-0.00554938059039538,0.206430474327983,0.0632929256409947
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21044.Average number of times bowels opened per day,32734,0.0933946530628617,0.0617543392173683,-0.0276438518031801,0.214433157928903,0.1304810709665
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32818,-0.00901484318479165,0.0546808191015781,-0.116189248623885,0.0981595622543014,0.869055809151588
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32813,0.045883144547865,0.0552417538706633,-0.062390693038635,0.154156982134365,0.406230066812324
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32816,-0.0437158984594624,0.0644344637958893,-0.170007447499405,0.0825756505804807,0.497501880358421
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32815,0.014391530086272,0.0574870906390105,-0.0982831675661886,0.127066227738733,0.802327726529417
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32812,0.0746204110907611,0.0850075179439593,-0.0919943240793991,0.241235146260921,0.38007230984572
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32813,0.0353668869191409,0.0627761484947311,-0.0876743641305321,0.158408137968814,0.573190608182935
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32813,0.0333368860590411,0.15952820661152,-0.279338398899537,0.34601217101762,0.834475395333484
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32818,0.0146296751012738,0.059785424062538,-0.102549756061301,0.131809106263848,0.806692374971647
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32816,-0.0605294336022215,0.0624024436401427,-0.182838223136901,0.0617793559324582,0.332082026253158
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32586,0.0301121831858093,0.0561778246152584,-0.0799963530600972,0.140220719431716,0.591962517768917
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32814,0.0577212662779562,0.0562200139887699,-0.0524699611400327,0.167912493695945,0.304589960303518
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32815,-0.0409128786146755,0.0746396126515693,-0.187206519411751,0.1053807621824,0.583611132392639
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32818,0.0344681315729598,0.0547479464161742,-0.0728378434027415,0.141774106548661,0.528987569239551
CCND2,G1/S-specific cyclin-D2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32817,0.0228073239194238,0.0548427105099616,-0.084684388680101,0.130299036518949,0.677517324820952
CCND2,G1/S-specific cyclin-D2,Working and living environment,X21100.Water hardness (USGS classification),48001,0.0480610443916135,0.0325113358025712,-0.015661173781426,0.111783262564653,0.139344686187847
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2139.Age first had sexual intercourse,44832,0.0021970375991852,0.00309421253441405,-0.00386761896826633,0.00826169416663673,0.477682860258425
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2149.Lifetime number of sexual partners,43523,-0.0907172874807849,0.0364279718985869,-0.162116112402015,-0.0193184625595546,0.0127712766818993
CCND2,G1/S-specific cyclin-D2,Physical activities,X22032.IPAQ activity group,42741,0.0643872347318388,0.0366104228361958,-0.00736919402710497,0.136143663490783,0.0786429530690068
CCND2,G1/S-specific cyclin-D2,Physical activities,X22033.Summed days activity,43334,0.00502788054137434,0.00289791117334629,-0.000652025358384389,0.0107077864411331,0.0827568375706175
CCND2,G1/S-specific cyclin-D2,Physical activities,X22034.Summed minutes activity,42741,0.00364580713352629,0.00291667572029454,-0.002070877278251,0.00936249154530358,0.211320240343027
CCND2,G1/S-specific cyclin-D2,Physical activities,X22037.MET minutes per week for walking,41836,0.0042939732321407,0.00297460775737662,-0.00153625797231748,0.0101242044365989,0.148885680407389
CCND2,G1/S-specific cyclin-D2,Physical activities,X22038.MET minutes per week for moderate activity,42741,0.00533789919637968,0.00288159596864905,-0.000310028902172452,0.0109858272949318,0.0639829713366247
CCND2,G1/S-specific cyclin-D2,Physical activities,X22039.MET minutes per week for vigorous activity,42741,0.0361777003202503,0.0363376040407734,-0.0350440035996656,0.107399404240166,0.319457951658475
CCND2,G1/S-specific cyclin-D2,Physical activities,X22040.Summed MET minutes per week for all activity,41836,0.00511802723402285,0.00303020099512032,-0.000821166716412971,0.0110572211844587,0.0912362407105528
CCND2,G1/S-specific cyclin-D2,Eye measures,X2217.Age started wearing glasses or contact lenses,44880,-0.000354410019810117,0.00277914336415545,-0.00580153101355481,0.00509271097393457,0.898526210490401
CCND2,G1/S-specific cyclin-D2,Working and living environment,X22501.Year ended full time education,30190,0.0135278038718515,0.0132016162847552,-0.0123473640462688,0.0394029717899717,0.305544110390478
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X22506.Tobacco smoking,30157,-0.222390061990561,0.138538622469848,-0.493925762031462,0.0491456380503399,0.108492675719624
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46604,0.0520711818093223,0.0769169016120406,-0.0986859453502772,0.202828308968922,0.498425896937121
CCND2,G1/S-specific cyclin-D2,Physical measures,X23098.Weight,47759,-0.000178901446959596,0.00607154165347123,-0.0120791230877632,0.011721320193844,0.976493528965693
CCND2,G1/S-specific cyclin-D2,Physical measures,X23099.Body fat percentage,47760,-0.0243509777692523,0.00621683005558147,-0.036535964678192,-0.0121659908603127,8.99339803178711e-05
CCND2,G1/S-specific cyclin-D2,Physical measures,X23100.Whole body fat mass,47754,-0.0127189433129834,0.00596273099770869,-0.0244058960684924,-0.00103199055747433,0.0329291174624439
CCND2,G1/S-specific cyclin-D2,Physical measures,X23101.Whole body fat-free mass,47759,0.0127071389987881,0.00498356727368948,0.00293934714235672,0.0224749308552195,0.0107845735642487
CCND2,G1/S-specific cyclin-D2,Physical measures,X23102.Whole body water mass,47759,0.0136223166401086,0.0050010315577541,0.00382029478691053,0.0234243384933066,0.00645638344490914
CCND2,G1/S-specific cyclin-D2,Physical measures,X23104.Body mass index (BMI),47759,0.00506211571587069,0.00981166297311499,-0.0141687437114347,0.0242929751431761,0.605909302171931
CCND2,G1/S-specific cyclin-D2,Physical measures,X23105.Basal metabolic rate,47757,0.0104901188850105,0.00543277515802143,-0.000158120424711486,0.0211383581947325,0.0535081417994486
CCND2,G1/S-specific cyclin-D2,Physical measures,X23106.Impedance of whole body,47753,-0.018798399343805,0.00406906232208307,-0.0267737614950878,-0.0108230371925222,3.86098158620749e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23107.Impedance of leg (right),47756,-0.0167830369037107,0.00334745108436734,-0.0233440410290707,-0.0102220327783507,5.37912230561695e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23108.Impedance of leg (left),47755,-0.0161191966711563,0.003309563026225,-0.0226059402025573,-0.00963245313975531,1.12051028740966e-06
CCND2,G1/S-specific cyclin-D2,Physical measures,X23109.Impedance of arm (right),47748,-0.0141689490113859,0.00408051851072179,-0.0221667652924006,-0.00617113273037114,0.000516877521627366
CCND2,G1/S-specific cyclin-D2,Physical measures,X23110.Impedance of arm (left),47754,-0.0158152863264451,0.00408771314530512,-0.0238272040912432,-0.00780336856164709,0.000109588321502234
CCND2,G1/S-specific cyclin-D2,Physical measures,X23111.Leg fat percentage (right),47755,-0.0491386324632836,0.00981234267715834,-0.068370824110514,-0.0299064408160533,5.54462953433536e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23112.Leg fat mass (right),47754,-0.0279348459803618,0.0112716776944062,-0.0500273342613979,-0.00584235769932564,0.0132072255240336
CCND2,G1/S-specific cyclin-D2,Physical measures,X23113.Leg fat-free mass (right),47754,0.0144144608803892,0.00507471996583247,0.00446800974735753,0.0243609120134208,0.00450897386169259
CCND2,G1/S-specific cyclin-D2,Physical measures,X23114.Leg predicted mass (right),47753,0.0139474314102733,0.00509556753486332,0.00396011904194123,0.0239347437786054,0.00620173677749193
CCND2,G1/S-specific cyclin-D2,Physical measures,X23115.Leg fat percentage (left),47750,-0.0502926088451868,0.0101274163852564,-0.0701423449602894,-0.0304428727300842,6.88359126356591e-07
CCND2,G1/S-specific cyclin-D2,Physical measures,X23116.Leg fat mass (left),47750,-0.026993626689086,0.0113229318590141,-0.0491865731327535,-0.00480068024541846,0.0171345578812915
CCND2,G1/S-specific cyclin-D2,Physical measures,X23117.Leg fat-free mass (left),47748,0.0131199139871115,0.00519938537828992,0.00292911864566326,0.0233107093285598,0.0116305747242427
CCND2,G1/S-specific cyclin-D2,Physical measures,X23118.Leg predicted mass (left),47747,0.0126942236396742,0.00522048909594551,0.00246206501162101,0.0229263822677274,0.0150391297276628
CCND2,G1/S-specific cyclin-D2,Physical measures,X23119.Arm fat percentage (right),47747,-0.0155068852010559,0.00688206778597675,-0.0289957380615703,-0.00201803234054148,0.0242538790760799
CCND2,G1/S-specific cyclin-D2,Physical measures,X23120.Arm fat mass (right),47745,-0.00506667044372212,0.00621540470835701,-0.0172488636721019,0.00711552278465761,0.414977910612093
CCND2,G1/S-specific cyclin-D2,Physical measures,X23121.Arm fat-free mass (right),47746,0.00718958334231746,0.00485897126313745,-0.00233400033343194,0.0167131670180669,0.138979840927688
CCND2,G1/S-specific cyclin-D2,Physical measures,X23122.Arm predicted mass (right),47745,0.0108365444022613,0.00485332476592599,0.00132402786104634,0.0203490609434762,0.0255710442706892
CCND2,G1/S-specific cyclin-D2,Physical measures,X23123.Arm fat percentage (left),47743,-0.0206947406123369,0.00772321991535129,-0.0358322516464254,-0.00555722957824841,0.00737733874668546
CCND2,G1/S-specific cyclin-D2,Physical measures,X23124.Arm fat mass (left),47743,-0.00540594966127348,0.00637662548071671,-0.0179041356034782,0.00709223628093126,0.396571476609457
CCND2,G1/S-specific cyclin-D2,Physical measures,X23125.Arm fat-free mass (left),47743,0.0104061446707742,0.00523191290828513,0.000151595370535379,0.0206606939710131,0.0467156273051483
CCND2,G1/S-specific cyclin-D2,Physical measures,X23126.Arm predicted mass (left),47741,0.0102749313383793,0.00524396595654138,-3.24193644177413e-06,0.0205531046132005,0.05008000440215
CCND2,G1/S-specific cyclin-D2,Physical measures,X23127.Trunk fat percentage,47740,-0.0122361562386667,0.0039269622295379,-0.019933002208561,-0.00453931026877242,0.00183585944556505
CCND2,G1/S-specific cyclin-D2,Physical measures,X23128.Trunk fat mass,47736,-0.00980688308251865,0.00453488247610048,-0.0186952527356756,-0.00091851342936171,0.030586414180472
CCND2,G1/S-specific cyclin-D2,Physical measures,X23129.Trunk fat-free mass,47732,0.0108377919991955,0.00465102670833329,0.00172177965086225,0.0199538043475287,0.0198044293027628
CCND2,G1/S-specific cyclin-D2,Physical measures,X23130.Trunk predicted mass,47729,0.010572811080234,0.00466123307678565,0.00143679424973414,0.0197088279107339,0.0233234962710435
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23400.Total Cholesterol,37714,0.0131597274552099,0.00348261956899319,0.00633379309998328,0.0199856618104366,0.000158347704821769
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37714,0.0114759548276659,0.0033648526799392,0.00488084357498509,0.0180710660803467,0.000650283330492544
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37714,0.0133830128177408,0.00335990788205199,0.00679759336891889,0.0199684322665627,6.83713856125951e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23403.VLDL Cholesterol,37714,0.0102965867683771,0.00329776546553145,0.00383296645593542,0.0167602070808187,0.00179834736118256
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37714,0.0102606829589893,0.00336699609235778,0.00366137061796809,0.0168599953000106,0.00231261775732457
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23405.LDL Cholesterol,37714,0.00922856473137128,0.00336684285609946,0.00262955273341633,0.0158275767293262,0.00613318489969769
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23406.HDL Cholesterol,37714,0.0073118599489698,0.00391000873361432,-0.000351757168914261,0.0149754770668539,0.061500730535027
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23407.Total Triglycerides,37714,0.00311707972218547,0.00357448375356651,-0.0038889084348049,0.0101230678791758,0.38320434092657
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23408.Triglycerides in VLDL,37714,0.00257367937277211,0.00357787071570905,-0.00443894723001762,0.00958630597556185,0.471948632522328
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23409.Triglycerides in LDL,37714,0.00562249533638061,0.00355849694591015,-0.00135215867760329,0.0125971493503645,0.114126199542844
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23410.Triglycerides in HDL,37714,0.00324727414141405,0.00336728565085417,-0.00335260573426012,0.00984715401708822,0.33488326854933
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37714,0.0129450845054611,0.0035529274262667,0.0059813467499784,0.0199088222609439,0.000269983869999486
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23412.Phospholipids in VLDL,37714,0.00788621726548065,0.00340007224266745,0.00122207566985245,0.0145503588611088,0.020387040023323
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23413.Phospholipids in LDL,37714,0.00926537409301551,0.0033410210804042,0.00271697277542328,0.0158137754106078,0.00555827387222806
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23414.Phospholipids in HDL,37714,0.00670467705523635,0.00378209706534784,-0.000708233192845403,0.0141175873033181,0.0762946487290079
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23415.Total Esterified Cholesterol,37714,0.0128619425603506,0.00349534010817456,0.00601107594832844,0.0197128091723727,0.000234396548564314
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37714,0.0112095258341367,0.00327622742924551,0.00478812007281549,0.0176309315954579,0.000624706414709829
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37714,0.00880657242161908,0.00336008558369296,0.00222080467758086,0.0153923401656573,0.00877885077958388
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37714,0.0062515777612311,0.00388351376947609,-0.00136010922694204,0.0138632647494042,0.107471101040383
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23419.Total Free Cholesterol,37714,0.0136260801059992,0.00344979666628635,0.006864478640078,0.0203876815719205,7.86141993794967e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37714,0.008860929181815,0.00335879969111245,0.00227768178723459,0.0154441765763954,0.00834634978800378
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23421.Free Cholesterol in LDL,37714,0.0100540173655621,0.00339480744593353,0.0034001947715324,0.0167078399595918,0.00306600503835368
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23422.Free Cholesterol in HDL,37714,0.0102457554283907,0.0039239510701407,0.00255481133091488,0.0179366995258664,0.00903580058891429
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37714,0.0123019626809638,0.00346828822826548,0.00550411775356344,0.0190998076083641,0.000391012941556251
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23424.Total Lipids in VLDL,37714,0.00663872781607636,0.00347071173744444,-0.000163867189314748,0.0134413228214675,0.055797005620162
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23425.Total Lipids in LDL,37714,0.0093032113036438,0.00335952861477624,0.00271853521868237,0.0158878873886052,0.00562719657833381
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23426.Total Lipids in HDL,37714,0.00740593440961668,0.00383124851296693,-0.000103312675798508,0.0149151814950319,0.0532532461587083
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37714,0.00542859804688339,0.00358112592951806,-0.001590408774972,0.0124476048687388,0.129570645241383
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23428.Concentration of VLDL Particles,37714,0.00892558252056102,0.00334704897057199,0.00236536653823991,0.0154857985028821,0.00766924862564304
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23429.Concentration of LDL Particles,37714,0.0105454030179085,0.00333123398195707,0.00401618441327265,0.0170746216225443,0.00155105761404018
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23430.Concentration of HDL Particles,37714,0.00359550522296171,0.00358848239077512,-0.00343792026295753,0.010628930708881,0.31638261873191
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37714,-0.00132466805233905,0.00377611958921921,-0.0087258624472087,0.00607652634253061,0.725742916041292
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37714,0.00110230376155927,0.00344165187602378,-0.00564333391544734,0.00784794143856589,0.748758596357749
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37714,0.0114584436616534,0.00409294575972577,0.0034362699725909,0.0194806173507159,0.00512463946276303
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23434.Phosphoglycerides,37701,0.0102064034657176,0.00357331212317908,0.00320271170428658,0.0172100952271486,0.00429294735485933
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37701,-0.00161187057241019,0.00379538315366957,-0.00905082155360254,0.00582708040878216,0.671067784233643
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23436.Total Cholines,37701,0.0111904834235589,0.00358308313054478,0.00416764048769111,0.0182133263594266,0.00179315911189545
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23437.Phosphatidylcholines,37701,0.0099953553043692,0.00358491472296275,0.0029689224473622,0.0170217881613762,0.00530821120968118
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23438.Sphingomyelins,37700,0.0121981427702912,0.00359936611548929,0.00514338518393221,0.0192529003566502,0.000703602222642547
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23439.Apolipoprotein B,37714,0.0113394939253894,0.0033296886687646,0.00481330413461081,0.017865683716168,0.000662213924284494
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23440.Apolipoprotein A1,37714,0.00555334030390226,0.00371058914154259,-0.00171941441352123,0.0128260950213257,0.134516073502977
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37714,0.00712923535213425,0.00336403341330333,0.000535729862059726,0.0137227408422088,0.0340876860905891
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23442.Total Fatty Acids,37701,0.0094463527455927,0.00357595480466953,0.00243748132844041,0.016455224162745,0.00826048058874869
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23443.Degree of Unsaturation,37701,-0.00335149636058229,0.00373379017889865,-0.0106697251112236,0.00396673239005908,0.369408536891001
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37701,0.000688397074256514,0.00348916269973407,-0.00615036181722226,0.00752715596573529,0.843599108508653
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37701,0.011540310642507,0.00345882909667981,0.00476100561301462,0.0183196156719995,0.000850801735141221
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37701,0.0100161900206661,0.00349110441024843,0.00317362537657914,0.016858754664753,0.00412343722130754
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37701,0.00787395582457725,0.00366872353491845,0.000683257696137089,0.0150646539530174,0.0318720589036228
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23448.Saturated Fatty Acids,37701,0.009245678333234,0.00365023479645709,0.00209121813217811,0.0164001385342899,0.0113237740794069
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23449.Linoleic Acid,37701,0.0136042243296638,0.00342252072317317,0.00689608371224442,0.0203123649470833,7.07782465631912e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23450.Docosahexaenoic Acid,37701,-0.000248828562231816,0.00366711895365749,-0.00743638171140049,0.00693872458693686,0.945902908528523
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37701,-0.00448845914616261,0.00347548381063878,-0.0113004074150146,0.0023234891226894,0.196565667487906
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37701,-0.000263161278527839,0.00391982930265196,-0.00794602671172568,0.00741970415467,0.946474525194218
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37701,-0.00286832504859155,0.00392688393564589,-0.0105650175624575,0.0048283674652744,0.465138556470581
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37701,0.00172026983092695,0.00387059436222884,-0.00586609511904158,0.00930663478089548,0.656727487148705
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37701,0.00263058191591285,0.00364404028050033,-0.00451173703386779,0.00977290086569349,0.470377266308132
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37701,0.00989267396179704,0.00376010779802047,0.00252286267767692,0.0172624852459172,0.0085243892649121
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37701,-0.00679554730677167,0.00370505027299713,-0.014057445841846,0.000466351228302706,0.0666569754890718
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37701,-0.00240386406257676,0.00391140228999888,-0.0100702125509746,0.00526248442582103,0.538843618053862
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37699,0.00403774117865415,0.00346308426189594,-0.00274990397466189,0.0108253863319702,0.243660547028359
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23460.Alanine,37708,-0.010968065680296,0.00335494318802998,-0.0175437543288347,-0.00439237703175723,0.00108117212748141
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23461.Glutamine,37671,0.000435729626783714,0.00338031266182231,-0.00618968319038801,0.00706114244395544,0.897437023106272
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23462.Glycine,37697,0.00417050923881306,0.00321430938219885,-0.00212953715029668,0.0104705556279228,0.194487919867355
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23463.Histidine,37695,-0.00178304581656001,0.00329514359606794,-0.00824152726485316,0.00467543563173315,0.588438637022583
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37705,-0.00116891625566445,0.00337005553802171,-0.007774225110187,0.0054363925988581,0.728706733657318
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23465.Isoleucine,37711,0.000398313020432563,0.00330403077287112,-0.00607758729439484,0.00687421333525997,0.904046397345475
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23466.Leucine,37712,-0.000627620139675006,0.00336825456861719,-0.00722939909416469,0.00597415881481468,0.852185744819119
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23467.Valine,37705,-0.00149155825627313,0.00339962849548235,-0.00815483010741855,0.00517171359487228,0.660855972846572
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23468.Phenylalanine,37710,0.00172467622973754,0.00329111702567258,-0.00472591314058071,0.00817526560005579,0.600259634619403
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23469.Tyrosine,37695,-0.000603313089979102,0.00332150192693982,-0.00711345686678115,0.00590683068682294,0.855869103464956
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23470.Glucose,37687,0.0042463744661847,0.00350924327566462,-0.00263174235411795,0.0111244912864873,0.226279717928816
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23471.Lactate,37685,-0.00667629535663126,0.00329632206288194,-0.0131370865998799,-0.000215504113382666,0.0428486849743451
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23472.Pyruvate,37673,-0.0069875693931586,0.00337574987443942,-0.0136040391470599,-0.000371099639257333,0.0384781780004746
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23473.Citrate,37712,0.0151638641261471,0.00335388914604754,0.00859024139989388,0.0217374868524002,6.20000766887207e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23474.3-Hydroxybutyrate,37552,-0.000448380668748793,0.00317527938275063,-0.00667192825894003,0.00577516692144244,0.887706350227645
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23475.Acetate,37704,0.00925397217577752,0.00340121127257888,0.00258759808152291,0.0159203462700321,0.00652116564812286
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23476.Acetoacetate,37713,0.00560729942544382,0.00327498457724313,-0.000811670345952718,0.0120262691968403,0.0868904633281418
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23477.Acetone,37713,0.00129920315879343,0.00329614134682606,-0.00516123388098565,0.00775964019857251,0.693470130204647
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23478.Creatinine,37320,0.0206096260568238,0.00395534452164956,0.0128571507943907,0.028362101319257,1.91164554074071e-07
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23479.Albumin,37712,0.00820067880632652,0.00338955318969181,0.00155715455453058,0.0148442030581225,0.0155595769930532
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23480.Glycoprotein Acetyls,37714,0.00287875852407486,0.00363066176078581,-0.00423733852706533,0.00999485557521504,0.427849177970565
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37714,0.00462314635103439,0.00361704365863626,-0.00246625921989268,0.0117125519219615,0.201216767625056
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37714,0.00554246310788031,0.0036149395077186,-0.00154281832724815,0.0126277445430088,0.125247858415471
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37714,0.00325782972300982,0.00356502237287227,-0.00372961412781982,0.0102452735738395,0.360822007734545
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37714,0.00435874496418282,0.00355813512837273,-0.00261519988742772,0.0113326898157934,0.220593860598654
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37714,0.00550872199204512,0.0035288528512517,-0.00140782959640821,0.0124252735804985,0.118535397085709
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37714,0.00373788815745636,0.00357913331726782,-0.00327721314438858,0.0107529894593013,0.296339902743506
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37714,0.00675631606202541,0.00363957473906869,-0.00037725042654923,0.0138898825506,0.0634261816665667
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37714,0.00277775081283947,0.0035429371671034,-0.00416640603468319,0.00972190766036213,0.433039526387325
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37714,0.002948465175466,0.00355119930108999,-0.00401188545467037,0.00990881580560238,0.406399351311878
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37714,0.00437688545708816,0.00352382045601783,-0.00252980263670679,0.0112835735508831,0.214227069399639
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37714,0.00543853226255108,0.00342341762494736,-0.00127136628234575,0.0121484308074479,0.112168559689262
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37714,0.0057308604362967,0.00335060044250423,-0.000836316431011596,0.012298037303605,0.0872156813544111
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37714,0.00509997567098265,0.00349946909460952,-0.001758983754452,0.0119589350964173,0.145041546002945
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37714,0.00152760006614408,0.00359268668719965,-0.00551406584076724,0.0085692659730554,0.670699875420651
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37714,0.0029454565289333,0.0035118168084053,-0.00393770441554109,0.0098286174734077,0.401637488044953
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37714,0.00271674117458093,0.00350377931982602,-0.00415066629227807,0.00958414864143993,0.43813221774238
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37714,0.00239641773033815,0.00348537907374639,-0.00443492525420477,0.00922776071488107,0.491740032056513
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37714,0.00497446593933213,0.0033864030367574,-0.00166288401271238,0.0116118158913766,0.141869333526894
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37714,0.00633767299735948,0.00330480610965904,-0.000139746977572234,0.0128150929722912,0.0551687372767314
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37714,0.0033258698175772,0.00347333926818417,-0.00348187514806376,0.0101336147832182,0.33831098225781
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37714,0.00146767030982499,0.00355731288464618,-0.00550466294408152,0.0084400035637315,0.679922229194899
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37714,0.00896963720702604,0.00332463604446197,0.00245335055988057,0.0154859238541715,0.00698602621788869
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37714,0.00724749434499438,0.00336178793611339,0.000658389990212145,0.0138365986997766,0.031113684781166
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37714,0.00925530449904607,0.00331573101876508,0.00275647170226652,0.0157541372958256,0.0052566733605121
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37714,0.011358441034779,0.00333737289397357,0.00481719016259083,0.0178996919069672,0.000667477042672591
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37714,0.0121093401941732,0.00339350775332834,0.00545806499764968,0.0187606153906968,0.000360456892705507
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37714,0.0100677724671423,0.00330640890952198,0.0035872110044792,0.0165483339298054,0.00233193572319005
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37714,0.00228903980793051,0.00349020892686904,-0.00455176968873281,0.00912984930459382,0.511934548084983
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37714,0.00548579302480741,0.00335201911046109,-0.00108416443169633,0.0120557504813112,0.101745379282314
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37714,0.00587087327192964,0.00333283148226923,-0.000661476433318054,0.0124032229771773,0.0781722540143446
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37714,0.00784590494297656,0.00329000932807769,0.00139748665994429,0.0142943232260088,0.017103917955477
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37714,0.00850248692204492,0.00325130331256438,0.00212993242941874,0.0148750414146711,0.00893019904748808
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37714,0.00798518457822115,0.00323281849558407,0.00164886032687638,0.0143215088295659,0.0135223588164564
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37714,0.00926679431459018,0.00329402917688952,0.00281049712788672,0.0157230915012936,0.00491218157780441
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37714,0.000706028105015701,0.00345855887852378,-0.00607274729689091,0.00748480350692231,0.838247704823849
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37714,0.0133621020054198,0.00336622766295346,0.00676429578603103,0.0199599082248086,7.24158073703951e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37714,0.0131905631353901,0.00336643345864312,0.00659235355644954,0.0197887727143306,8.96379170749187e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37714,0.0121488669018038,0.00336173856445788,0.00555985931546638,0.0187378744881413,0.000302783389985806
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37714,0.0158261943441167,0.00342334280333255,0.00911644244958495,0.0225359462386485,3.81755800284122e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37714,0.0165382481586629,0.00344874065814709,0.00977871646869458,0.0232977798486312,1.64077709844487e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37714,0.0136306212342385,0.00337384682989939,0.00701788144763575,0.0202433610208413,5.37334524538424e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37714,0.0036892403016463,0.00343417427270366,-0.00304174127285287,0.0104202218761455,0.282719939250989
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23523.Concentration of IDL Particles,37714,0.013947114577471,0.00337723996607827,0.00732772424395758,0.0205665049109844,3.65402795250359e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23524.Total Lipids in IDL,37714,0.0147178586290695,0.00347305210515922,0.00791067650295739,0.0215250407551815,2.27317058953619e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23525.Phospholipids in IDL,37714,0.0148079019201487,0.00348231286792183,0.00798256869902191,0.0216332351412755,2.13018256879508e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23526.Cholesterol in IDL,37714,0.0145120942587598,0.00347948001984509,0.00769231341986345,0.0213318750976562,3.05509862260555e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37714,0.0139465738276107,0.00347368413236969,0.00713815292816606,0.0207549947270553,5.97925542219253e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23528.Free Cholesterol in IDL,37714,0.0157305453242924,0.00349114041969208,0.00888791010169595,0.0225731805468889,6.66738819883805e-06
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23529.Triglycerides in IDL,37714,0.00631340970196596,0.00348171460746744,-0.00051075092867021,0.0131375703326021,0.0698074231256916
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37714,0.0106370240330769,0.00334862670510415,0.0040737156910728,0.0172003323750811,0.00149388184780401
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23531.Total Lipids in Large LDL,37714,0.0101190278929746,0.00338719930986376,0.00348011724564166,0.0167579385403076,0.00281846447331042
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23532.Phospholipids in Large LDL,37714,0.0103411337151167,0.00337022254690419,0.00373549752318449,0.0169467699070489,0.0021565470888455
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23533.Cholesterol in Large LDL,37714,0.0099216845214435,0.00339810144659045,0.00326140568612622,0.0165819633567608,0.0035087603973046
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37714,0.00926976033808467,0.00338452741843926,0.00263608659794373,0.0159034340782256,0.00617341994331835
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37714,0.0114775277937899,0.00343253560191156,0.00474975801404326,0.0182052975735366,0.000828842494631062
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23536.Triglycerides in Large LDL,37714,0.00590819939674884,0.00352987484694526,-0.00101035530326388,0.0128267540967616,0.0941993493465541
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37714,0.00917189508620905,0.00332208401086112,0.00266061042492125,0.0156831797474969,0.00577240316853127
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37714,0.00729757619500566,0.00333740260957416,0.000756267080240318,0.013838885309771,0.0287888949029787
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37714,0.0070579509927542,0.0033128639763928,0.000564737599024309,0.0135511643864841,0.0331513354139219
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37714,0.00731529414943572,0.00333769305520533,0.000773415761233261,0.0138571725376382,0.0284169368541346
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37714,0.00707011283547484,0.00335000100516305,0.000504110865355255,0.0136361148055944,0.0348356348194509
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37714,0.00750351525373309,0.00333946021670534,0.00095817322899063,0.0140488572784756,0.0246612251451599
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37714,0.00463461154616443,0.0035822549765417,-0.00238660820785731,0.0116558313001862,0.195767647966719
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37714,0.0110265073483041,0.00330950315535735,0.00453988116380374,0.0175131335328046,0.000865310140147943
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23545.Total Lipids in Small LDL,37714,0.00899309132163926,0.00334288169066232,0.00244104320794112,0.0155451394353374,0.00714940776441581
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23546.Phospholipids in Small LDL,37714,0.00882898497208128,0.00332980179802903,0.00230257344794439,0.0153553964962182,0.00802292806571318
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23547.Cholesterol in Small LDL,37714,0.00883688629559328,0.00333281709340701,0.00230456479251554,0.015369207798671,0.00802359599597229
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37714,0.00921591223393752,0.0033545714520032,0.00264095218801125,0.0157908722798638,0.00601748499555306
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37714,0.00725481755199452,0.00331711361529366,0.000753274866018941,0.0137563602379701,0.0287535451446941
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23550.Triglycerides in Small LDL,37714,0.00552788458952639,0.00361227442626744,-0.00155217328595779,0.0126079424650106,0.125964898496866
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37714,0.0158641468500242,0.0038876672853565,0.00824431897072542,0.0234839747293229,4.51759883500615e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37714,0.015007718495588,0.00391097638146765,0.00734220478791144,0.0226732322032646,0.000124954647866987
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37714,0.0143950737916112,0.00390958913065067,0.00673227909553591,0.0220578684876866,0.000232337755858834
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37714,0.014697881052104,0.00388923530628866,0.00707497985177827,0.0223207822524298,0.000158073559484491
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37714,0.0142721807075805,0.00395342433902719,0.0065234690030872,0.0220208924120738,0.000307230156553835
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37714,0.0156710401872743,0.00361659062618043,0.00858252255996069,0.022759557814588,1.48108056280903e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37714,0.0104207912500995,0.00349295476331573,0.00357459991400067,0.0172669825861983,0.00285608116838676
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37714,0.0120227517269927,0.00412352272538152,0.00394064718524497,0.0201048562687405,0.00355541972904659
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23559.Total Lipids in Large HDL,37714,0.0109254763907639,0.00410091749632347,0.00288767809796991,0.0189632746835579,0.00772755220940083
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23560.Phospholipids in Large HDL,37714,0.00961784025744163,0.00404605820337135,0.00168756617883378,0.0175481143360495,0.0174639798609813
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23561.Cholesterol in Large HDL,37714,0.0112895932779928,0.00410378740387571,0.00324616996639642,0.0193330165895892,0.00594909780192958
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37714,0.0108673066009348,0.00409175409263401,0.00284746857937215,0.0188871446224975,0.00791906941451554
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37714,0.0124812628732437,0.00409737464889405,0.00445040856141134,0.020512117185076,0.00232238965179522
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23564.Triglycerides in Large HDL,37714,0.00825162827301457,0.00344819371031056,0.00149316860080587,0.0150100879452233,0.016723732405299
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37714,0.00388972192883295,0.00367797330241953,-0.00331910574390933,0.0110985496015752,0.290269833272093
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37714,0.00340175352058789,0.00364369901115796,-0.00373989654128172,0.0105434035824575,0.350527811243252
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37714,0.00338771413713086,0.00361824108940905,-0.00370403839811087,0.0104794666723726,0.349142197904766
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37714,0.00273054044728704,0.00369324568521215,-0.00450822109572878,0.00996930199030286,0.459717566508273
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37714,0.00198424459077334,0.00367406582033489,-0.00521692441708304,0.00918541359862973,0.589159354477835
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37714,0.00559411587904862,0.00374088639888895,-0.00173802146277373,0.012926253220871,0.134834268098861
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37714,0.00246471033184348,0.00333672082203566,-0.00407526247934642,0.00900468314303338,0.460125072579694
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37714,-0.00238512624455683,0.00329784945729677,-0.00884891118085851,0.00407865869174484,0.469547139493648
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23573.Total Lipids in Small HDL,37714,-0.00161608786484475,0.00333467469608609,-0.00815205026917347,0.00491987453948398,0.627945882631303
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23574.Phospholipids in Small HDL,37714,-0.00112675378757771,0.00337006546200224,-0.0077320820931021,0.00547857451794669,0.738126930725533
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23575.Cholesterol in Small HDL,37714,-0.00256933241591356,0.00330490750550188,-0.00904695112669724,0.00390828629487012,0.436919311824893
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37714,-0.00408694638261734,0.00326631369395379,-0.0104889212227668,0.00231502845753208,0.210868549107743
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37714,0.0026281363905498,0.00343080690999463,-0.00409624515303967,0.00935251793413927,0.443665951037208
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23578.Triglycerides in Small HDL,37714,-0.00105921479033956,0.00344772993078552,-0.00781676545467917,0.00569833587400005,0.758680040564924
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.0075747430544514,0.00313672978204355,-0.0137227334272568,-0.00142675268164605,0.0157557529169041
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.0037664530661353,0.00327816863603284,-0.0101916635927597,0.00265875746048906,0.25059836033122
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.00145779514471486,0.00319631084777415,-0.00772256440635219,0.00480697411692248,0.648335469407801
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,-0.00734582180292002,0.00334323676032458,-0.0138985658531562,-0.000793077752683846,0.0280230665051088
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36992,0.00542742214264955,0.00317673991645728,-0.000798988093606718,0.0116538323789058,0.0875705713790391
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37515,0.00977545241781741,0.00308285094418402,0.00373306456721674,0.0158178402684181,0.00152311760760048
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37515,0.0065743551844978,0.00351804199568345,-0.000321007127041763,0.0134697174960374,0.0616794050247644
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37515,0.00497833856681087,0.0035263862530766,-0.00193337848921927,0.011890055622841,0.158050513363328
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37515,0.0109714586213091,0.00332517222663905,0.00445412105709654,0.0174887961855216,0.000971109571849738
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37515,-0.00866076296140115,0.00337672341257069,-0.0152791408500397,-0.0020423850727626,0.0103333399293807
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37709,0.00136091712533269,0.00330265121988344,-0.00511227926563885,0.00783411351630424,0.680296191329904
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37709,0.00608480011821956,0.00324610419493009,-0.000277564103843419,0.0124471643402825,0.0608844553692161
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37709,0.00806962844595,0.00340689160137776,0.00139212090724959,0.0147471359846504,0.0178688858609226
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37709,0.00323970244465212,0.00311609626438116,-0.00286784623353495,0.00934725112283919,0.298513599616664
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37709,-0.00501031382587499,0.00305899704751616,-0.0110059480390067,0.000985320387256686,0.10146747783787
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37714,0.0134139214544242,0.00342506139397215,0.00670080112223878,0.0201270417866096,9.03301437477553e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37714,0.0111182025184971,0.00358947944050727,0.00408282281510282,0.0181535822218913,0.0019560654519921
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37714,0.0103876156149201,0.00361967725221431,0.00329304820058004,0.0174821830292601,0.00411428916506145
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37714,0.0126163720423324,0.00350311224382923,0.00575027204442707,0.0194824720402376,0.000317572528883183
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37714,-0.0118080090767184,0.00356081233386751,-0.0187872012510987,-0.00482881690233807,0.000915283786058727
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37714,0.00954005068495425,0.00349757405193683,0.00268480554315807,0.0163952958267504,0.00638771138650457
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37714,0.00972728602350409,0.00340824508443515,0.0030471256580112,0.016407446388997,0.0043233252919163
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37714,0.00828972944097191,0.00331163446543084,0.00179892588872748,0.0147805329932164,0.0123190395004835
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37714,0.0101090903227758,0.00350816772365503,0.00323308158441196,0.0169850990611397,0.00396312846139441
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37714,-0.00991099501698931,0.00343940442538643,-0.0166522276907467,-0.0031697623432319,0.00396293802268822
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37714,-0.00657527279204337,0.00351189142317286,-0.0134585799814622,0.000308034397375442,0.061188733641363
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37714,0.0135384069038371,0.00364395173687474,0.00639626149956263,0.0206805523081116,0.000203788833409914
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37714,0.0137076432747369,0.00367101113174788,0.00651246145651108,0.0209028250929628,0.000189233149384363
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37714,0.00859817525539543,0.00353834247244754,0.00166302400939825,0.0155333265013926,0.0151119655419527
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37714,-0.0129012629594178,0.00363394082920409,-0.0200237869846578,-0.00577873893417777,0.000386252743411031
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37714,-0.00347056507573206,0.00328171111594604,-0.00990271886298629,0.00296158871152217,0.29028109396306
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37714,0.00795654832252958,0.00348005220752855,0.00113564599577362,0.0147774506492855,0.0222506420616245
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37714,0.00390720401306082,0.00347469552034963,-0.00290319920682446,0.0107176072329461,0.260832438688921
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37714,0.00956865481823301,0.00354170628640684,0.0026269104968756,0.0165103991395904,0.00690721111496766
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37714,-0.00871442052663537,0.00358997744042911,-0.0157507763098764,-0.00167806474339433,0.0152194255504349
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37714,0.000330068643853681,0.00327521240246544,-0.00608934766497858,0.00674948495268594,0.919728387260991
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37714,0.00427886657824016,0.00360242169272465,-0.00278187993950015,0.0113396130959805,0.234943321553016
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37714,-0.00377222529985034,0.00331372057709964,-0.0102671176309656,0.00272266703126496,0.254988442391486
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37714,0.0108280740748054,0.00359029009754327,0.00379110548362055,0.0178650426659902,0.0025667513052312
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37714,-0.00562969891145341,0.00357598178507404,-0.0126386232101985,0.00137922538729171,0.115439973911054
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37714,-0.00246483628276596,0.00324145251948808,-0.0088180832209626,0.00388841065543068,0.447022444276911
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37714,0.00529142539565172,0.00332357750484061,-0.00122278651383587,0.0118056373051393,0.111388932773814
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37714,0.00272239869717446,0.00337969178720665,-0.00390179720575057,0.0093465946000995,0.42053592620875
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37714,0.00167997921087775,0.00366401148624632,-0.00550148330216504,0.00886144172392055,0.64659490564655
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37714,-0.00446106447269232,0.00344986043258522,-0.0112227909205594,0.00230066197517471,0.195993993066619
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37714,-0.0038183902692259,0.00330783498195241,-0.0103017468338526,0.00266496629540082,0.248378625885138
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37714,0.00527570159366828,0.00333904073516318,-0.00126881824725155,0.0118202214345881,0.11412953293561
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37714,0.00596190518495019,0.00333875520672778,-0.000582055020236261,0.0125058653901366,0.0741760249264745
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37714,-0.000944726649473148,0.00358061155240283,-0.0079627252921827,0.0060732719932364,0.791903415417018
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37714,-0.00258413607283721,0.00353313065624816,-0.0095090721590836,0.00434080001340919,0.464547042878968
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37712,0.0092650018486314,0.00379873245879123,0.0018194862294006,0.0167105174678622,0.0147421375550539
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37712,-0.00905350717326303,0.0037884904252114,-0.0164789484066774,-0.00162806593984869,0.0168741844128597
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37712,-0.00454309106229832,0.00380154606489192,-0.0119941213494865,0.00290793922488984,0.23208337725362
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37712,-0.00785358723247429,0.00404923818901092,-0.0157900940829357,8.29196179871171e-05,0.0524589693037985
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37712,-0.00439750334665036,0.00379623941539695,-0.0118381326008284,0.00304312590752766,0.246728190454739
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37714,-0.0132180516531179,0.00393611256473277,-0.0209328322799941,-0.0055032710262417,0.00078687182681754
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37714,0.00872934005933454,0.00393211276618002,0.0010223990376217,0.0164362810810474,0.0264347517433865
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37714,0.00568747491942301,0.00396670111226969,-0.00208725926062558,0.0134622090994716,0.151651563321332
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37714,0.0163678173510873,0.00381144588947089,0.00889738340772441,0.0238382512944503,1.76423876302423e-05
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37714,-0.0014434854320335,0.00382529591005275,-0.00894106541573689,0.00605409455166989,0.70591761098154
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37714,-0.00255427493338038,0.00371841681822014,-0.00984237189709185,0.00473382203033109,0.492141755360527
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37714,0.000280464364479423,0.00363272842596212,-0.00683968335040634,0.00740061207936519,0.938461723716403
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37714,-0.00220420498559231,0.0036049443714884,-0.00926989595370956,0.00486148598252495,0.540919212934465
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37714,0.010840123553119,0.00391603369612794,0.00316469750870822,0.0185155495975298,0.00564557189478095
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37714,0.00127039715149049,0.00353624878694014,-0.00566065047091218,0.00820144477389316,0.719413842247026
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37714,0.0023818683687337,0.00342646997426459,-0.0043340127808249,0.0090977495182923,0.48698120565843
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37714,-0.00138196485335592,0.00344801227676004,-0.00814006891580559,0.00537613920909376,0.688573508244102
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37714,-0.00481847925867541,0.00345696787361961,-0.0115941362909698,0.00195717777361902,0.163387606441981
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37714,0.0112832176218143,0.0035345089886984,0.00435558000396544,0.0182108552396632,0.00141473346214896
CCND2,G1/S-specific cyclin-D2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37714,-0.000409720686760503,0.00353405922514685,-0.00733647676804833,0.00651703539452732,0.907705917355664
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47858,0.00132128045767388,0.00285695635817474,-0.00427835400434862,0.00692091491969637,0.643742624740872
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47858,0.00241737488122473,0.00279880061002677,-0.00306827431442774,0.00790302407687719,0.387751592009089
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46180,0.00609360076713013,0.00268288949248968,0.000835137361850365,0.0113520641724099,0.0231396010486955
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46180,0.00300671429919279,0.00293436994738396,-0.00274465079767976,0.00875807939606535,0.305537818855627
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46180,-0.00156403287349553,0.00286797916973817,-0.00718527204618235,0.00405720629919128,0.585523111051638
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46180,0.00663599280270814,0.00263067751319193,0.00147986487685196,0.0117921207285643,0.0116581056527128
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24009.Traffic intensity on the nearest road,47858,-0.0482495504935214,0.0710741388595364,-0.187554862658213,0.0910557616711698,0.497231853169898
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24010.Inverse distance to the nearest road,47858,-0.000600134573055397,0.00250371594615475,-0.0055074178275187,0.00430714868140791,0.810566834929627
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24011.Traffic intensity on the nearest major road,47858,0.00618164834499179,0.00250182142400974,0.0012780783539327,0.0110852183360509,0.0134859578195373
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24012.Inverse distance to the nearest major road,47858,-0.00154679245628979,0.00255432859730907,-0.00655327650701556,0.00345969159443598,0.544814602527069
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24013.Total traffic load on major roads,47858,0.0299998148198738,0.0500153048256894,-0.0680301826384774,0.128029812278225,0.548636877900383
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24015.Sum of road length of major roads within 100m,47858,5.51222853430763e-05,0.0483103456297571,-0.0946331551489808,0.0947433997196669,0.999089620648896
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47858,0.000376030137591295,0.00284483480037985,-0.00519984607115321,0.00595190634633579,0.894843091290626
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47858,0.000642496204325492,0.0028392167805295,-0.00492236868551233,0.00620736109416331,0.82097515645082
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47858,0.000306105405610411,0.00281302188581931,-0.00520741749059544,0.00581962830181626,0.913348346205729
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47800,0.00117653222185829,0.00276518012699191,-0.00424322082704586,0.00659628527076244,0.670489828550904
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24020.Average daytime sound level of noise pollution,47858,-0.00122214751398094,0.00252436197419384,-0.00616989698340085,0.00372560195543898,0.628290227473659
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24021.Average evening sound level of noise pollution,47858,-0.00115401514295895,0.00252437331198797,-0.00610178683445537,0.00379375654853747,0.647568079299707
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24022.Average night-time sound level of noise pollution,47858,-0.00122672598706321,0.00252432962080389,-0.00617441204383884,0.00372096006971241,0.626999299322186
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47858,-0.00115140890678766,0.00252425274036552,-0.00609894427790409,0.00379612646432876,0.648294604837012
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47858,-0.00115599228484571,0.00252434690280469,-0.0061037122143429,0.00379172764465148,0.647001830267055
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45197,-0.000332374593430649,0.00293604030930914,-0.00608701359967656,0.00542226441281526,0.909869086576119
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45197,-7.40393689339221e-05,0.00267678900593533,-0.00532054582056717,0.00517246708269932,0.977933776159621
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24502.Water percentage, buffer 1000m",45197,-0.00153658254600483,0.00262117654129824,-0.00667408856694938,0.00360092347493971,0.557734975406438
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45197,-0.00146003681556373,0.00276390928469333,-0.00687729901356266,0.00395722538243521,0.597331044803724
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45197,-0.000353782278150443,0.00270222338738399,-0.00565014011742307,0.00494257556112218,0.89583775712154
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24505.Water percentage, buffer 300m",45197,-0.000268820279513555,0.00264196885525501,-0.00544707923581338,0.00490943867678627,0.918956112658418
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48001,-0.00319464675475696,0.0027850774670913,-0.00865339859025591,0.00226410508074198,0.251369101868037
CCND2,G1/S-specific cyclin-D2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48001,-0.00709752253219907,0.00262774689104604,-0.0122479064386493,-0.00194713862574883,0.00691825148739175
CCND2,G1/S-specific cyclin-D2,Working and living environment,X24508.Distance (Euclidean) to coast,48001,-0.00336469846814804,0.0024979891978819,-0.00826075729599656,0.00153136035970047,0.178005182703369
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34078,-0.0366107754343914,0.0538455801409414,-0.142148112510636,0.0689265616418537,0.496570427689041
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2704.Years since last cervical smear test,42463,0.0597216816137192,0.0382063180023553,-0.0151627016708971,0.134606064898336,0.118038114825418
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2714.Age when periods started (menarche),47412,-0.00206469550384183,0.0324225103455187,-0.0656128157810585,0.0614834247733749,0.949224846611901
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2734.Number of live births,48141,-0.00337441039557854,0.0312062797745033,-0.0645387187536049,0.0577898979624478,0.913891571536937
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2744.Birth weight of first child,43298,-0.00885954159125561,0.0346897961292971,-0.0768515420046779,0.0591324588221666,0.798422131653869
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2754.Age at first live birth,40515,0.000680890877281008,0.00317425616156718,-0.00554065119939066,0.00690243295395267,0.830156713521363
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2764.Age at last live birth,40468,0.00234184387064786,0.00305746148933643,-0.00365078064845154,0.00833446838974727,0.44372099179138
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2794.Age started oral contraceptive pill,42576,-0.000708300924066748,0.00349926805880605,-0.0075668663193266,0.0061502644711931,0.83959533879712
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2804.Age when last used oral contraceptive pill,40893,0.000250932116372854,0.003055290906167,-0.00573743805971446,0.00623930229246017,0.934544057345575
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2867.Age started smoking in former smokers,29299,-0.00133954160040856,0.00580966419359677,-0.0127264834198582,0.0100474002190411,0.817657627147438
CCND2,G1/S-specific cyclin-D2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33747,-0.0219831573851421,0.0561301979441538,-0.131998345355684,0.0880320305853995,0.695328907786992
CCND2,G1/S-specific cyclin-D2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33738,-0.0794739620506614,0.0608036209936397,-0.198649059198195,0.0397011350968725,0.191224811625837
CCND2,G1/S-specific cyclin-D2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33768,0.0388551333781154,0.0678505619006766,-0.0941319679472108,0.171842234703442,0.56689043954625
CCND2,G1/S-specific cyclin-D2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33729,0.0887178169981905,0.0648991640786196,-0.0384845445959039,0.215920178592285,0.171655249802435
CCND2,G1/S-specific cyclin-D2,Mental health,X28739.Difficulty with standing for long periods,33783,-0.0492588795298438,0.0567852268346199,-0.160557924125699,0.0620401650660112,0.385712655174935
CCND2,G1/S-specific cyclin-D2,Mental health,X28740.Difficulty with taking care of household responsibilities,33807,-0.0231911432197131,0.0618554894704813,-0.144427902581856,0.0980456161424302,0.707725062151168
CCND2,G1/S-specific cyclin-D2,Mental health,X28741.Difficulty learning a new task,33711,0.159568020875622,0.0697124398720213,0.0229316387264605,0.296204403024784,0.0221048994315781
CCND2,G1/S-specific cyclin-D2,Mental health,X28742.Difficulty with joining in community activities,33466,0.112437957819057,0.0738849657029313,-0.0323765749586881,0.257252490596802,0.128094911001478
CCND2,G1/S-specific cyclin-D2,Mental health,X28743.Difficulty with being emotionally affected by health problems,33743,0.0349410401275461,0.0610828583071108,-0.084781362154391,0.154663442409483,0.567317571784572
CCND2,G1/S-specific cyclin-D2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33798,0.0218406003325409,0.090243076638693,-0.155035829879297,0.198717030544379,0.808770227508426
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29277,-0.0371836394066245,0.0712129110092447,-0.176760944984744,0.102393666171495,0.601591650601219
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2897.Age stopped smoking,29306,0.00530964190030723,0.00596779975842072,-0.00638724562619738,0.0170065294268118,0.37366293588688
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32842,0.00883655272922425,0.00867803560356503,-0.0081723970537632,0.0258455025122117,0.308580697038331
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32842,-0.00985450477289026,0.0092532770340124,-0.0279909277595546,0.00828191821377404,0.286918082853807
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32842,-0.0224105897501306,0.0310079781068877,-0.0831862268396306,0.0383650473393694,0.469862086777652
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32842,0.0284049640431925,0.0331361657726884,-0.0365419208712768,0.0933518489576618,0.391348128872014
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32842,-0.046782440618117,0.0349520709635308,-0.115288499706637,0.0217236184704034,0.180778216831644
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32842,-0.0337713809766344,0.0280232905551828,-0.0886970304647926,0.0211542685115238,0.228191615917394
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32842,-0.0119984028241988,0.013100080892385,-0.0376745613732733,0.0136777557248757,0.359744119604509
CCND2,G1/S-specific cyclin-D2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32842,-0.00153090632658919,0.0227079007052891,-0.0460383917089559,0.0429765790557775,0.946251069468852
CCND2,G1/S-specific cyclin-D2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32789,0.0180776743018628,0.0683147959796537,-0.115819325818258,0.151974674421984,0.791306352513355
CCND2,G1/S-specific cyclin-D2,Mental health,X29003.Recent feelings of depression,32777,0.0742498397515891,0.0653687445767875,-0.0538728996189144,0.202372579122093,0.256047242288029
CCND2,G1/S-specific cyclin-D2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32794,0.0576822973041568,0.0530170678355316,-0.0462311556534852,0.161595750261799,0.276628816587162
CCND2,G1/S-specific cyclin-D2,Mental health,X29005.Recent feelings of tiredness or low energy,32802,-0.0169344758522179,0.0542275852734277,-0.123220542988136,0.0893515912837004,0.754831536838191
CCND2,G1/S-specific cyclin-D2,Mental health,X29006.Recent poor appetite or overeating,32807,0.0792946961467689,0.0710884984687426,-0.0600387608519666,0.218628153145504,0.264695563497604
CCND2,G1/S-specific cyclin-D2,Mental health,X29007.Recent feelings of inadequacy,32764,0.0914907241089286,0.0714564078738222,-0.0485638353237629,0.23154528354162,0.200450367490425
CCND2,G1/S-specific cyclin-D2,Mental health,X29008.Recent trouble concentrating on things,32806,0.118397335900475,0.0725003301041097,-0.0237033111035799,0.26049798290453,0.102494226881578
CCND2,G1/S-specific cyclin-D2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32795,0.262888822914095,0.132340359379545,0.00350171853018605,0.522275927298004,0.047014946564138
CCND2,G1/S-specific cyclin-D2,Mental health,X29010.Recent thoughts of suicide or self-harm,32737,-0.0549256721645559,0.142716305401363,-0.334649630751228,0.224798286422116,0.700351673688142
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#0.Substances taken for depression_None of options listed,31908,0.0272948771099914,0.0167051795349276,-0.00544727477846674,0.0600370289984495,0.102318495553149
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31908,-0.0275280517934543,0.0332092859114877,-0.0926182521799702,0.0375621485930616,0.407172625027515
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31908,0.0318371912402465,0.0156853654161274,0.00109387502463672,0.0625805074558563,0.0424185594330901
CCND2,G1/S-specific cyclin-D2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31908,-0.00287329092530818,0.0465084540146927,-0.0940298607941058,0.0882832789434894,0.950739710020522
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31908,0.041995489752093,0.0290514649356906,-0.0149453815218605,0.0989363610260466,0.148344090820271
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31908,0.0316800769742911,0.0300527893025581,-0.0272233900587229,0.090583544007305,0.291849485235993
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31908,-0.0204622673629054,0.0362870042817144,-0.0915847957550655,0.0506602610292548,0.572838669080405
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31908,-0.0193485968403576,0.0398258759474857,-0.0974073136974295,0.0587101200167143,0.627102129611436
CCND2,G1/S-specific cyclin-D2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31908,0.0221368692967369,0.0299033633975916,-0.0364737229625427,0.0807474615560165,0.459153272538502
CCND2,G1/S-specific cyclin-D2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31908,0.0130521597981336,0.0168240232276892,-0.0199229257281373,0.0460272453244045,0.43788879179578
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31908,0.00227789982095846,0.025428895261856,-0.0475627348922792,0.0521185345341962,0.928624028523288
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31908,0.000587385278563643,0.039272752825597,-0.0763872102596064,0.0775619808167337,0.988067236883325
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31908,-0.0113414654367244,0.0518449693469223,-0.112957605356692,0.0902746744832433,0.826845099418651
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31908,0.0293850879712903,0.0343770850793942,-0.0379939987843222,0.0967641747269029,0.392696499720902
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31908,0.0266521339341728,0.0576585610792222,-0.0863586457811027,0.139662913649448,0.64392220339007
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31908,-0.0322966344536857,0.0532306086845094,-0.136628627475324,0.0720353585679527,0.544048243259682
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31908,0.00214788388301141,0.0289426035371424,-0.0545796190497876,0.0588753868158105,0.940843815128442
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31908,0.0177629980747445,0.0281212343937639,-0.0373546213370328,0.0728806174865218,0.527629850188357
CCND2,G1/S-specific cyclin-D2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31908,0.0110912352472082,0.0391041573736773,-0.0655529132051994,0.0877353836996157,0.776699406758718
CCND2,G1/S-specific cyclin-D2,Mental health,X29058.Recent feelings or nervousness or anxiety,32672,-0.0111236674196911,0.059969123272687,-0.128663149034158,0.106415814194775,0.852849369456611
CCND2,G1/S-specific cyclin-D2,Mental health,X29059.Recent inability to stop or control worrying,32682,-0.00340532899818681,0.0617612658878797,-0.124457410138431,0.117646752142057,0.956030682672891
CCND2,G1/S-specific cyclin-D2,Mental health,X29060.Recent worrying too much about different things,32676,0.0396192891049227,0.0580025992182693,-0.0740658053628851,0.15330438357273,0.494587808828007
CCND2,G1/S-specific cyclin-D2,Mental health,X29061.Recent trouble relaxing,32682,-0.0266818825233489,0.0612269383964489,-0.146686681780389,0.0933229167336908,0.663002961053143
CCND2,G1/S-specific cyclin-D2,Mental health,X29062.Recent restlessness,32690,0.0620278017821692,0.0896694546698313,-0.1137243293707,0.237779932935038,0.489121149555574
CCND2,G1/S-specific cyclin-D2,Mental health,X29063.Recent easy annoyance or irritability,32657,0.0767013313319796,0.0648380671671343,-0.0503812803156035,0.203783942979563,0.236856280858248
CCND2,G1/S-specific cyclin-D2,Mental health,X29064.Recent feelings of foreboding,32650,0.0608305639102119,0.0700476294713996,-0.0764627898537313,0.198123917674155,0.385191427809821
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31908,0.00545998571091027,0.0167440670772028,-0.0273583857604072,0.0382783571822277,0.744369350804426
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31908,0.0758293523236663,0.0285066679127645,0.0199562832146479,0.131702421432685,0.00782946685064104
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31908,0.0445201094473454,0.036215592486621,-0.0264624518264318,0.115502670721123,0.218995225497443
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31908,0.0393957141702319,0.0400683028148065,-0.0391381593467888,0.117929587687253,0.325534054678663
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31908,-0.0239317739271253,0.0274740713092425,-0.0777809536932407,0.0299174058389901,0.383745277444635
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31908,0.0264213870153497,0.0271767012797333,-0.0268449474929277,0.079687721523627,0.330978974290206
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31908,0.0108731708968366,0.0278368970880847,-0.0436871473958094,0.0654334891894826,0.696101989737604
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31908,0.00713570478973187,0.0251363909784297,-0.0421316215279904,0.0564030311074541,0.776510649593061
CCND2,G1/S-specific cyclin-D2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31908,-0.0440866565137227,0.0338319705944653,-0.110397318878875,0.0222240058514294,0.192578688134716
CCND2,G1/S-specific cyclin-D2,Mental health,X29076.Felt loved as a child,32653,-0.0232243681337181,0.0568879272104351,-0.134724705466171,0.0882759691987348,0.68310245914866
CCND2,G1/S-specific cyclin-D2,Mental health,X29077.Physically abused by family as a child,32667,0.0783775149370181,0.0812900671694807,-0.080951016715164,0.2377060465892,0.334988656267299
CCND2,G1/S-specific cyclin-D2,Mental health,X29078.Felt hated by family member as a child,32648,0.028584991319352,0.0746386747021528,-0.117706811096868,0.174876793735571,0.701745803615611
CCND2,G1/S-specific cyclin-D2,Mental health,X29079.Sexually molested as a child,32559,0.0886769509605064,0.0954897346153535,-0.0984829288855865,0.275836830806599,0.353095939171813
CCND2,G1/S-specific cyclin-D2,Mental health,X29080.Someone to take to doctor when needed as a child,32631,0.00487949298566412,0.0798892704789232,-0.151703477153025,0.161462463124354,0.951298422043051
CCND2,G1/S-specific cyclin-D2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32646,-0.115074698252161,0.0989299088229944,-0.30897731954523,0.0788279230409077,0.244784586916222
CCND2,G1/S-specific cyclin-D2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32583,-0.128527964958201,0.0734591873595256,-0.272507972182871,0.0154520422664692,0.080216223872072
CCND2,G1/S-specific cyclin-D2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32648,-0.255221306098772,0.0808189856691587,-0.413626518010323,-0.0968160941872212,0.00159466348699111
CCND2,G1/S-specific cyclin-D2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32608,0.00383127339866519,0.104590630207645,-0.201166361808319,0.208828908605649,0.970780015360234
CCND2,G1/S-specific cyclin-D2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32617,-0.0790053816936505,0.102331713548113,-0.279575540247951,0.12156477686065,0.440106107032549
CCND2,G1/S-specific cyclin-D2,Mental health,X29086.Experienced a violent or sexual assault,32647,-0.0529096831586009,0.0964134538308921,-0.241880052667149,0.136060686349948,0.583172044637981
CCND2,G1/S-specific cyclin-D2,Mental health,X29087.Experienced a life-threatening injury or illness,32660,0.0165010330594912,0.0683982718346167,-0.117559579736357,0.15056164585534,0.80936795420095
CCND2,G1/S-specific cyclin-D2,Mental health,X29088.Experienced a marital separation or divorce,32660,-0.0386657488550559,0.0606871466616542,-0.157612556311898,0.0802810586017864,0.524056362008834
CCND2,G1/S-specific cyclin-D2,Mental health,X29089.Experienced the death of a spouse or partner,32668,-0.111075027123203,0.0754781365930322,-0.259012174845546,0.0368621205991405,0.141162214005
CCND2,G1/S-specific cyclin-D2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32653,0.00317496008194187,0.0778261557922463,-0.149364305270861,0.155714225434745,0.967459887846691
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29091.Frequency of drinking alcohol,32664,-0.0258458605252059,0.0505488646889099,-0.124921635315469,0.0732299142650576,0.609151626389555
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31584,-0.0821202499894773,0.0621660084966689,-0.203965626642948,0.0397251266639938,0.186549380025051
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31601,-0.0286500428498592,0.0646897830637897,-0.155442017654887,0.0981419319551686,0.657863348916542
CCND2,G1/S-specific cyclin-D2,Mental health,X29104.Ever used cannabis,32658,-0.124590348448891,0.0787358340188982,-0.278912583125931,0.0297318862281498,0.113600415934935
CCND2,G1/S-specific cyclin-D2,Mental health,X29108.Ever thought that life not worth living,32614,0.11420229979848,0.0625205403296364,-0.00833795924760726,0.236742558844568,0.0677909543979259
CCND2,G1/S-specific cyclin-D2,Mental health,X29109.Ever contemplated self-harm,32641,0.0495360696740334,0.0829696881046788,-0.113084519011137,0.212156658359204,0.550498413598807
CCND2,G1/S-specific cyclin-D2,Mental health,X29111.Ever self-harmed,32655,0.00104280097454238,0.13037517678215,-0.254492545518471,0.256578147467556,0.993618412757574
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32647,0.0348886299047297,0.0882511777428804,-0.138083678471316,0.207860938280775,0.692607213319619
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32507,-0.00944297823903567,0.0352136807031116,-0.0784617924171345,0.0595758359390631,0.788581333120056
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32507,-0.00493433912920856,0.0278390442309575,-0.0594988658218853,0.0496301875634682,0.859320188583008
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32507,0.0175874251314021,0.0281463416736814,-0.0375794045490135,0.0727542548118176,0.53208293013185
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32507,0.000727920856836759,0.0367460763044868,-0.0712943886999573,0.0727502304136309,0.984195841871104
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32642,-0.0308407367295352,0.0564804471097554,-0.141542413064656,0.0798609396055854,0.585051449816242
CCND2,G1/S-specific cyclin-D2,Health and medical history,X29153.Pain or discomfort today,32653,-0.0249305552391427,0.0538469935977672,-0.130470662690766,0.080609552212481,0.643384680790352
CCND2,G1/S-specific cyclin-D2,Mental health,X29154.Anxiety or depression today,32653,0.0489132129526913,0.0654608528620079,-0.0793900586568443,0.177216484562227,0.454956311180709
CCND2,G1/S-specific cyclin-D2,Mental health,X29166.Frequency of confiding in someone close,32447,-0.0501593030207198,0.0526290080681228,-0.15331215883424,0.0529935527928008,0.340581754415902
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32624,0.00424342765569646,0.00926834829595347,-0.0139225350043723,0.0224093903157653,0.647079020374252
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32624,-0.00282320748201303,0.00910964673414275,-0.0206781150809328,0.0150317001169068,0.756634223153757
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32624,-0.0127826786092961,0.0133899760221852,-0.039027031612779,0.0134616743941869,0.339785302652065
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32624,-0.000695161630777136,0.0115814616952746,-0.0233948265535154,0.0220045032919612,0.952138264512927
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32624,-0.0253506505173239,0.0170550974461631,-0.0587786415118035,0.00807734047715566,0.13721264557761
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32624,-0.000929241136231976,0.00907106197432343,-0.0187085226059059,0.016850040333442,0.918409813284892
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32623,-0.0079842847138891,0.0100435714929787,-0.0276696848401274,0.0117011154123492,0.426657131258143
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32623,-0.0054087351837576,0.0140509991414543,-0.0329486935010079,0.0221312231334927,0.700294863592337
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32623,-0.00851813604254255,0.0298261267911096,-0.0669773445531174,0.0499410724680323,0.775197027175066
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32623,0.027359296260332,0.0193630255836986,-0.0105922338837171,0.0653108264043812,0.157703819180496
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32623,-0.0377193420184578,0.0268646466593536,-0.0903740494707909,0.0149353654338753,0.160341580763472
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32623,0.00758205570940487,0.0142653769957295,-0.020378083202225,0.0355421946210348,0.595086408910511
CCND2,G1/S-specific cyclin-D2,Mental health,X29171.Frequency of feeling 'in tune' with people,32530,0.0932094831065637,0.0653458065860083,-0.0348682978020125,0.22128726401514,0.153790572367064
CCND2,G1/S-specific cyclin-D2,Mental health,X29172.Freuency of feeling that lacks companionship,32603,0.0452149043727765,0.0589601709282617,-0.0703470306466164,0.160776839392169,0.443179834054549
CCND2,G1/S-specific cyclin-D2,Mental health,X29173.Frequency of feeling left out,32551,0.0203858826525553,0.0611721432204125,-0.0995115180594533,0.140283283364564,0.73895092490477
CCND2,G1/S-specific cyclin-D2,Mental health,X29174.Frequency of feeling isolated from others,32578,0.0632391116418966,0.0639690904928972,-0.062140305724182,0.188618529007975,0.322893919515808
CCND2,G1/S-specific cyclin-D2,Mental health,X29175.Tendency to bounce back quickly after hard times,32641,0.00420517955279453,0.0530740030526182,-0.0998198664303372,0.108230225535926,0.936849727089197
CCND2,G1/S-specific cyclin-D2,Mental health,X29176.Ability to make it through stressful events,32641,0.0163666238801584,0.0517003150343217,-0.0849659935871122,0.117699241347429,0.751580100584456
CCND2,G1/S-specific cyclin-D2,Mental health,X29177.Quick recovery from stressful events,32641,-0.0712723893333785,0.0524493676596434,-0.17407314994628,0.0315283712795226,0.174222100831093
CCND2,G1/S-specific cyclin-D2,Mental health,X29178.Hard to snap back when something bad happens,32641,0.0366196901383644,0.051779449443618,-0.0648680307711269,0.138107411047856,0.47944716874157
CCND2,G1/S-specific cyclin-D2,Mental health,X29179.Comes through difficult times with little trouble,32641,-0.0801568071629209,0.0522757399961811,-0.182617257555436,0.022303643229594,0.125229221979047
CCND2,G1/S-specific cyclin-D2,Mental health,X29180.Tendency to take a long time to get over setbacks,32641,0.0408838217525572,0.0520293296216402,-0.0610936643058576,0.142861307810972,0.432016706198431
CCND2,G1/S-specific cyclin-D2,Mental health,X29181.General happiness,32594,-0.00457070403508006,0.0547056402794845,-0.11179375898287,0.10265235091271,0.933415582496379
CCND2,G1/S-specific cyclin-D2,Mental health,X29182.Belief that own life is meaningful,32504,-0.0612059023811486,0.054268077644606,-0.167571334564576,0.0451595298022792,0.259419607186244
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28906,-0.0632711555692893,0.0716884383768215,-0.203780494787859,0.0772381836492807,0.377508062245067
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2946.Father's age,29723,0.0073111155882626,0.00807965286637199,-0.00852500402982651,0.0231472352063517,0.365570365822603
CCND2,G1/S-specific cyclin-D2,Health and medical history,X2966.Age high blood pressure diagnosed,29484,-0.00528095441617314,0.00634134915943298,-0.0177099987686618,0.0071480899363155,0.405007835210511
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47377,0.00170742206603175,0.00264634855912827,-0.00347942110985967,0.00689426524192317,0.518804538637828
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47377,-0.000111395690549941,0.00312327725935815,-0.00623301911889191,0.00601022773779203,0.971548766252176
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30020.Haemoglobin concentration,47377,-0.00411325037666477,0.00339352141212853,-0.0107645523444367,0.00253805159110714,0.225490760474304
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30030.Haematocrit percentage,47377,-0.000768626918403082,0.00329188417786853,-0.0072207199070254,0.00568346607021923,0.815381867180518
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30040.Mean corpuscular volume,47377,-0.000800797936455273,0.00260457492127299,-0.00590576478215034,0.00430416890923979,0.758497421930722
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47376,-0.00427596380246636,0.00261150047574184,-0.00939450473492036,0.000842577129987645,0.101569205718942
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47376,-0.00635297738804878,0.00256148295676539,-0.0113734839833089,-0.00133247079278862,0.0131381770590477
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47377,0.00649021438491233,0.00246628885644025,0.00165628822628943,0.0113241405435352,0.00850479862167134
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30080.Platelet count,47377,-0.00304066627311127,0.00261205691836698,-0.00816029783311056,0.00207896528688801,0.244400130710928
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30090.Platelet crit,47377,-0.00361691360030198,0.00267855257885857,-0.00886687665486478,0.00163304945426082,0.176925435044942
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47377,-0.000113525736894444,0.00252535293707706,-0.00506321749356548,0.00483616601977659,0.964144043836367
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30110.Platelet distribution width,47377,-0.000235831333024394,0.00252885837951822,-0.00519239375688011,0.00472073109083132,0.925700965096854
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30120.Lymphocyte count,47346,0.0160043125828923,0.00262424924255753,0.0108607840674796,0.0211478410983051,1.08698383568959e-09
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30130.Monocyte count,47346,0.00849565614768634,0.00267057296926646,0.00326133312792407,0.0137299791674486,0.00146856408676282
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30140.Neutrophill count,47346,-0.00768991810932346,0.00262896982473734,-0.0128426989658087,-0.00253713725283827,0.00344717746432021
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30150.Eosinophill count,47346,0.0159649395759724,0.0025899984824621,0.0108885425503467,0.0210413366015982,7.20816339138365e-10
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30160.Basophill count,47346,0.062919730487479,0.0350115536153811,-0.00570291459866797,0.131542375573626,0.0723308014724839
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30170.Nucleated red blood cell count,47346,0.0702457009488086,0.157674607488445,-0.238796529728543,0.379287931626161,0.655955050787454
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30180.Lymphocyte percentage,47346,0.0169450577481255,0.00259405470020388,0.0118607105357259,0.0220294049605251,6.61417935448553e-11
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30190.Monocyte percentage,47346,0.00727759725115955,0.00263418702151749,0.00211459068898527,0.0124406038133338,0.00573625848892564
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30200.Neutrophill percentage,47346,-0.0205000590016556,0.002572220275042,-0.0255416107407379,-0.0154585072625733,1.66316483406932e-15
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30210.Eosinophill percentage,47346,0.0152863394287071,0.00255942687454629,0.0102698627545964,0.0203028161028178,2.3700105733542e-09
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30220.Basophill percentage,47346,0.00493067328003806,0.00245565033540549,0.000117598622643299,0.00974374793743281,0.0446668153384628
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47346,0.0649984452061625,0.157725870441555,-0.244144260859286,0.374141151271611,0.68027178088376
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30240.Reticulocyte percentage,46942,-0.00547374120176136,0.0027051429473983,-0.010775821378662,-0.000171661024860689,0.0430378266042544
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30250.Reticulocyte count,46942,-0.0056580584270103,0.00279588546688517,-0.0111379939421052,-0.000178122911915374,0.0430119088431083
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30260.Mean reticulocyte volume,46942,0.00309471732777902,0.00258167262436015,-0.00196536101596687,0.00815479567152492,0.23064725142979
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30270.Mean sphered cell volume,46942,0.00178704090913815,0.00261067281196191,-0.00332987780230719,0.0069039596205835,0.493657990972725
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30280.Immature reticulocyte fraction,46942,-0.00090027282169998,0.00272922852603519,-0.00624956073272894,0.00444901508932898,0.741506190692575
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46942,-0.00442186587626097,0.00277880656900538,-0.00986832675151152,0.00102459499898959,0.111560099494438
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30300.High light scatter reticulocyte count,46942,-0.0047966442293991,0.0028494965530025,-0.010381657473284,0.000788369014485793,0.0923250236403285
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30500.Microalbumin in urine,31052,-0.00190619592286679,0.00497276085244621,-0.0116528071936614,0.00784041534792778,0.701489307060246
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47421,-0.00221885077551084,0.00270260677804752,-0.00751596006048398,0.00307825850946231,0.411652552666543
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30520.Potassium in urine,47377,0.000956853450613521,0.00251652953804176,-0.00397554444394834,0.00588925134517538,0.70378015387814
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30530.Sodium in urine,47352,0.00276692217621922,0.00264648047949418,-0.00242017956358936,0.00795402391602781,0.295798292199795
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30600.Albumin,44983,0.00197287047806233,0.00277722732441427,-0.00347049507778964,0.00741623603391429,0.477480222477581
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30610.Alkaline phosphatase,47006,0.0108598726339077,0.00263924015783298,0.00568696192455505,0.0160327833432603,3.88937453719184e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30620.Alanine aminotransferase,47015,0.0129246523020697,0.00274631064519923,0.00754188343747922,0.0183074211666602,2.53889751316954e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30630.Apolipoprotein A,44783,0.00162660940414225,0.00306415530510117,-0.00437913499385604,0.00763235380214054,0.595527947911223
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30640.Apolipoprotein B,46914,0.00253304669600771,0.00262197951966645,-0.00260603316253853,0.00767212655455396,0.334013651466545
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30650.Aspartate aminotransferase,46949,0.0256770339664125,0.0026446776943202,0.0204934656855449,0.0308606022472801,3.05390119811333e-22
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30660.Direct bilirubin,41972,-0.00597980607611037,0.00301783865983787,-0.0118947698493926,-6.48423028281496e-05,0.0475523656930553
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30670.Urea,47004,0.0113404824031009,0.00275714767105181,0.00593647296783935,0.0167444918383624,3.91729157728414e-05
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30680.Calcium,44984,-0.00709507590304548,0.00267040652100645,-0.0123290726842181,-0.00186107912187284,0.00789174491980952
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30690.Cholesterol,47016,0.00934502355452145,0.00269924079510132,0.00405451159612287,0.01463553551292,0.000536983882303885
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30700.Creatinine,47010,0.0165825215678981,0.00305337129826975,0.0105979138232894,0.0225671293125068,5.66531635287318e-08
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30710.C-reactive protein,46959,-0.0056806504311839,0.00287315312911319,-0.0113120305642458,-4.9270298122045e-05,0.0480370288278233
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30720.Cystatin C,47013,0.0134901328514273,0.00297316854595818,0.00766272250134922,0.0193175432015053,5.72750113816124e-06
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30730.Gamma glutamyltransferase,47012,0.00413148463362919,0.00270754289640447,-0.00117529944332358,0.00943826871058195,0.127044655921803
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30740.Glucose,44962,-0.00314021852954543,0.00288628766345368,-0.00879734234991464,0.00251690529082379,0.276617443741159
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46927,0.0189451160733406,0.0029034218515886,0.013254409244227,0.0246358229024543,6.94039251334882e-11
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30760.HDL cholesterol,44971,0.0071614655468909,0.00321315142501447,0.000863688753862539,0.0134592423399193,0.0258381341411878
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30770.IGF-1,46886,-0.00420336670656429,0.0026430296839741,-0.00938370488715354,0.000976971474024948,0.111767940732972
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30780.LDL direct,46967,0.0065095521707299,0.00262845772832393,0.001357775023215,0.0116613293182448,0.0132725558032286
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30790.Lipoprotein A,42528,0.00550688319056871,0.00288260792164628,-0.000143028335858002,0.0111567947169954,0.056099812473176
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30810.Phosphate,44942,0.00799843812165956,0.00287624587153245,0.00236099621345597,0.0136358800298632,0.00542645451488049
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30830.SHBG,44755,-0.00436339883885518,0.00303305109977036,-0.0103081789944051,0.00158138131669471,0.150274484982693
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30840.Total bilirubin,46936,-0.00832692186338467,0.0026511759554171,-0.0135232267360022,-0.00313061699076716,0.00168681849460971
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30850.Testosterone,43153,0.00207078262273712,0.00463361259320803,-0.00701109805995061,0.0111526633054249,0.65494914275778
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30860.Total protein,44979,-0.00370887393173255,0.00271895453259283,-0.00903802481561449,0.00162027695214938,0.172557063010473
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30870.Triglycerides,47010,0.00125191374266658,0.00292753336067742,-0.00448605164426117,0.00698987912959433,0.668921455994306
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30880.Urate,46983,0.0014777642098112,0.00323490240132843,-0.00486264449679252,0.00781817291641493,0.647805700840757
CCND2,G1/S-specific cyclin-D2,Blood and urine assays,X30890.Vitamin D,45698,0.00482104117013537,0.00288735812432895,-0.000838180753549365,0.0104802630938201,0.0949921416379901
CCND2,G1/S-specific cyclin-D2,Physical measures,X3137.Number of measurements made,46055,0.011495042311346,0.0394371519218443,-0.0658017754554689,0.0887918600781609,0.770688950936319
CCND2,G1/S-specific cyclin-D2,Physical measures,X3143.Ankle spacing width,37827,-0.00405575927739475,0.00461336384955911,-0.0130979524225306,0.0049864338677411,0.379345092595826
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37826,0.00180109180105596,0.0037459089926069,-0.00554088982445356,0.00914307342656548,0.630655366272442
CCND2,G1/S-specific cyclin-D2,Physical measures,X3146.Speed of sound through heel,37827,-4.86864604372022e-05,0.00361682363222347,-0.0071376607795952,0.0070402878587208,0.989260113357753
CCND2,G1/S-specific cyclin-D2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37827,0.000599951115787778,0.00366161295818091,-0.0065768102822468,0.00777671251382235,0.869852600939942
CCND2,G1/S-specific cyclin-D2,Physical measures,X3148.Heel bone mineral density (BMD),37825,0.000415351819626886,0.00365263807892602,-0.00674381881506811,0.00757452245432188,0.909467147151464
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3526.Mother's age at death,38577,0.00206083004572696,0.00331880935432323,-0.00444403628874658,0.0085656963802005,0.534639492630956
CCND2,G1/S-specific cyclin-D2,Health and medical history,X3581.Age at menopause (last menstrual period),38030,-0.00296281202518906,0.0033577949408828,-0.00954409010931935,0.00361846605894124,0.377593258870046
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29349,0.000973076160749052,0.00576546473494148,-0.0103272347197363,0.0122733870412344,0.865979249929904
CCND2,G1/S-specific cyclin-D2,Physical measures,X4100.Ankle spacing width (left),32165,0.000240999662588929,0.00579002149262418,-0.0111074424629545,0.0115894417881323,0.96680009512162
CCND2,G1/S-specific cyclin-D2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32164,-0.00438999551399733,0.00468926743565222,-0.0135809596878757,0.00480096865988101,0.349210148389753
CCND2,G1/S-specific cyclin-D2,Physical measures,X4103.Speed of sound through heel (left),32165,-0.00475183898913193,0.0045777723865359,-0.0137242728667423,0.00422059488847843,0.299291280678165
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32165,-0.00461195549704401,0.00461405185561541,-0.0136554971340502,0.00443158613996218,0.317561789376489
CCND2,G1/S-specific cyclin-D2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32163,-0.00476441885491529,0.00460143512151866,-0.0137832316930919,0.0042543939832613,0.300505187774744
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32165,-0.00460959600899636,0.00461374882780085,-0.013652543711486,0.00443335169349331,0.31777764040548
CCND2,G1/S-specific cyclin-D2,Physical measures,X4119.Ankle spacing width (right),32164,-0.000263203580136733,0.00571676546707317,-0.0114680638956001,0.0109416567353267,0.963279044805353
CCND2,G1/S-specific cyclin-D2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32164,-0.00283207479533825,0.00469968568423795,-0.0120434587364446,0.00637930914576813,0.546786280427346
CCND2,G1/S-specific cyclin-D2,Physical measures,X4122.Speed of sound through heel (right),32164,-0.00302021437944452,0.00459763946204,-0.0120315877250429,0.00599115896615387,0.511261321306095
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32164,-0.00305674504571857,0.00462799271640722,-0.0121276107698767,0.00601412067843958,0.50895886486663
CCND2,G1/S-specific cyclin-D2,Physical measures,X4124.Heel bone mineral density (BMD) (right),32161,-0.00318666933225,0.00462071719737578,-0.0122432750391065,0.00586993637460652,0.490436202020587
CCND2,G1/S-specific cyclin-D2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32164,-0.00306128158993092,0.00462800294902706,-0.012132167370024,0.00600960419016213,0.50833119687855
CCND2,G1/S-specific cyclin-D2,Physical measures,X4194.Pulse rate,32404,-0.00999960945918162,0.00453690513171399,-0.018891943517341,-0.00110727540102221,0.0275486969506984
CCND2,G1/S-specific cyclin-D2,Physical measures,X4195.Pulse wave reflection index,32404,-0.00181031615157897,0.00449179573605661,-0.0106142357942499,0.00699360349109198,0.686939001747245
CCND2,G1/S-specific cyclin-D2,Physical measures,X4196.Pulse wave peak to peak time,32401,0.00408338539318748,0.00410025533085066,-0.0039531150552798,0.0121198858416548,0.319336028530397
CCND2,G1/S-specific cyclin-D2,Physical measures,X4198.Position of the pulse wave peak,32404,-0.00125025121331032,0.00398408944490949,-0.00905906652533292,0.00655856409871229,0.753672797712306
CCND2,G1/S-specific cyclin-D2,Physical measures,X4199.Position of pulse wave notch,32404,-0.00765831487430755,0.00444339029326377,-0.0163673598491045,0.00105073010048944,0.0848316607953265
CCND2,G1/S-specific cyclin-D2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32404,-0.00382236900475507,0.00397077888759377,-0.0116050956244389,0.00396035761492873,0.33576527304694
CCND2,G1/S-specific cyclin-D2,Physical measures,X4269.Number of triplets attempted (left),32315,-0.204548318054061,0.182300685358273,-0.561857661356276,0.152761025248154,0.261880555910236
CCND2,G1/S-specific cyclin-D2,Physical measures,X4270.Volume level set by participant (left),32235,-0.143109024172427,0.0564333979810365,-0.253718484215258,-0.0324995641295953,0.0112355191544329
CCND2,G1/S-specific cyclin-D2,Physical measures,X4276.Number of triplets attempted (right),32318,0.075194355837136,0.173366441041115,-0.26460386860345,0.414992580277722,0.664495891133724
CCND2,G1/S-specific cyclin-D2,Physical measures,X4277.Volume level set by participant (right),32227,-0.157798331635134,0.0562246798296533,-0.267998704101254,-0.0475979591690134,0.00501971229011942
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4288.Time to answer,32463,0.00443692018760047,0.00509067864836576,-0.00554080996319641,0.0144146503383974,0.383465112575552
CCND2,G1/S-specific cyclin-D2,Cognitive function,X4290.Duration screen displayed,32463,-0.000533177638724917,0.00446961344312807,-0.00929361998725594,0.00822726470980611,0.905049048687141
CCND2,G1/S-specific cyclin-D2,Physical measures,X46.Hand grip strength (left),48071,0.00365271028835722,0.00381123763247971,-0.00381731547130301,0.0111227360480174,0.337868241564488
CCND2,G1/S-specific cyclin-D2,Physical measures,X47.Hand grip strength (right),48074,0.00311187930045055,0.00380475877208602,-0.00434544789283806,0.0105692064937392,0.413427477870611
CCND2,G1/S-specific cyclin-D2,Physical measures,X48.Waist circumference,48148,-0.012634090553479,0.00506690141570858,-0.0225652173282678,-0.00270296377869021,0.0126574290214505
CCND2,G1/S-specific cyclin-D2,Health and medical history,X4803.Tinnitus,32313,0.0310668168313961,0.0680844269209381,-0.102378659933643,0.164512293596435,0.648188006417754
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4825.Noisy workplace,32441,0.104049455216069,0.0976846468506411,-0.0874124526111876,0.295511363043326,0.286837227051709
CCND2,G1/S-specific cyclin-D2,Working and living environment,X4836.Loud music exposure frequency,32388,0.109967376083682,0.111466337191334,-0.108506644811332,0.328441396978696,0.323892227357682
CCND2,G1/S-specific cyclin-D2,Physical measures,X49.Hip circumference,48146,0.00116815425198287,0.00430687391234465,-0.00727331861621264,0.00960962712017839,0.786216353501646
CCND2,G1/S-specific cyclin-D2,Physical measures,X50.Standing height,48143,-0.000600032408638585,0.00352220430220139,-0.00750355284095331,0.00630348802367614,0.864730785620915
CCND2,G1/S-specific cyclin-D2,Health and medical history,X5057.Number of older siblings,31515,-0.0314700099331716,0.0594325715536575,-0.14795785017834,0.085017830311997,0.596469882713576
CCND2,G1/S-specific cyclin-D2,Physical measures,X51.Seated height,48036,-0.00409445001961874,0.00353427940717451,-0.0110216376576808,0.00283273761844329,0.246673244890521
CCND2,G1/S-specific cyclin-D2,Eye measures,X5181.Ever had eye surgery,29848,0.0994997307486518,0.13804981398029,-0.171077904652716,0.37007736615002,0.471093118559424
CCND2,G1/S-specific cyclin-D2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29834,0.0107474607878379,0.00520464499769111,0.000546356592363319,0.0209485649833125,0.0389731687408736
CCND2,G1/S-specific cyclin-D2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29835,0.0031588017920008,0.0051804343682794,-0.00699484956982683,0.0133124531538284,0.54204907997381
CCND2,G1/S-specific cyclin-D2,Eye measures,X5190.Duration at which refractometer first shown (right),29767,0.00475961738911926,0.00523167574951593,-0.00549446707993195,0.0150137018581705,0.362985501732783
CCND2,G1/S-specific cyclin-D2,Eye measures,X5193.Duration at which refractometer first shown (left),29767,-0.000490612403632835,0.00526146590981318,-0.0108030855868667,0.009821860779601,0.925711380645071
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5199.logMAR, initial (right)",29816,-0.0539990248895615,0.0708694022897073,-0.192903053377388,0.0849050035982647,0.446122647015608
CCND2,G1/S-specific cyclin-D2,Eye measures,X5200.Final number of letters displayed (right),29816,-0.328586958737745,0.535762246714527,-1.37868096229822,0.721507044822728,0.539699104951736
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5201.logMAR, final (right)",29773,-0.000832086601088992,0.00541649453841505,-0.0114484158963825,0.00978424269420451,0.877914506207437
CCND2,G1/S-specific cyclin-D2,Eye measures,X5202.Number of rounds to result (right),29816,-0.10316300591617,0.0666114462562636,-0.233721440578447,0.0273954287461068,0.12150625684447
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5206.logMAR, initial (left)",29816,0.125714534654173,0.0705615367465605,-0.0125860773690855,0.264015146677432,0.0748661976835716
CCND2,G1/S-specific cyclin-D2,Eye measures,X5207.Final number of letters displayed (left),29816,0.395096884442528,0.412479512729918,-0.413362960508112,1.20355672939317,0.33817745119237
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5208.logMAR, final (left)",29762,0.00606729637096153,0.00536103286162774,-0.00444032803782884,0.0165749207797519,0.25779478417256
CCND2,G1/S-specific cyclin-D2,Eye measures,X5209.Number of rounds to result (left),29814,0.0341662478763,0.06665569323239,-0.0964789108591845,0.164811406611784,0.608267640131532
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29566,-0.000756267442088566,0.00535121970700288,-0.0112446580678142,0.00973212318363708,0.887617834655965
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29566,-0.00405809758494945,0.00538205204777259,-0.0146069195985837,0.00649072442868483,0.4508805514692
CCND2,G1/S-specific cyclin-D2,Eye measures,X5256.Corneal hysteresis (right),29566,-0.00417861075966509,0.00531815749921519,-0.0146021994581269,0.00624497793879669,0.432064854603578
CCND2,G1/S-specific cyclin-D2,Eye measures,X5257.Corneal resistance factor (right),29566,-0.00458813548810043,0.00531559171553864,-0.0150066952505562,0.00583042427435531,0.388097287045167
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29556,0.00254438403315646,0.00536888953899387,-0.00797863946327153,0.0130674075295844,0.635582553594299
CCND2,G1/S-specific cyclin-D2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29556,-0.00207716133006804,0.00531366147853819,-0.0124919378280029,0.00833761516786682,0.69588036700511
CCND2,G1/S-specific cyclin-D2,Eye measures,X5264.Corneal hysteresis (left),29556,-0.00701709306334237,0.00542775436497839,-0.0176554916187,0.00362130549201528,0.19613287990285
CCND2,G1/S-specific cyclin-D2,Eye measures,X5265.Corneal resistance factor (left),29556,-0.00641185883742872,0.00535804278191494,-0.016913622689982,0.00408990501512457,0.231487163461937
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29178,-0.0954443317848966,0.325332032526219,-0.733095115536286,0.542206451966493,0.769248306669355
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48071,-0.00522358221104616,0.0146403442191743,-0.0339186568806278,0.0234714924585355,0.721249459335212
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48071,0.00386787305150075,0.0152368893594328,-0.0259964300929875,0.033732176195989,0.799614227100144
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48071,0.00666744151287329,0.0397816013572288,-0.0713044971472951,0.0846393801730416,0.866898513669693
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48071,-0.00619772758047743,0.0064274944013356,-0.0187956166070952,0.00640016144614034,0.334929218393792
CCND2,G1/S-specific cyclin-D2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48071,0.00441463583938192,0.00587998988205128,-0.0071101443294386,0.0159394160082024,0.45278670880501
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35355,0.00176850666947269,0.00730087194345588,-0.0125412023397008,0.0160782156786462,0.808604759763129
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35355,-0.00574851049294169,0.0179905077886537,-0.041009905758703,0.0295128847728196,0.749330618838839
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35355,-0.01360073422253,0.0142588513059188,-0.0415480827821309,0.0143466143370709,0.340183246170359
CCND2,G1/S-specific cyclin-D2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35355,0.00224763130649604,0.00876880868087723,-0.0149392337080233,0.0194344963210154,0.797707687288867
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48139,-0.000598480062043282,0.0120238892876192,-0.024165303065777,0.0229683429416904,0.960302707053778
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48139,-0.000598480062043282,0.0120238892876192,-0.024165303065777,0.0229683429416904,0.960302707053778
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48139,0.000494256850549543,0.00971027201337399,-0.0185378762956635,0.0195263899967626,0.95940530603503
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48139,-0.00734622036632028,0.014942309049632,-0.0366331461035989,0.0219407053709584,0.622979195185088
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48139,-0.0373882392542106,0.0378767201332313,-0.111626610715344,0.0368501322069227,0.323602033430267
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48139,0.0203877884897166,0.025736831167195,-0.0300564005979856,0.0708319775774189,0.428273049404409
CCND2,G1/S-specific cyclin-D2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48139,0.071370062270514,0.0407670665832134,-0.00853338823258416,0.151273512773612,0.0800141004608649
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48071,0.0033783112660906,0.00781982065252873,-0.0119485372128657,0.0187051597450469,0.665731532188143
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48071,0.00830363058723774,0.0130643194888262,-0.0173024356108616,0.0339096967853371,0.525045866493679
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48071,0.00457026659348771,0.00694480871138184,-0.0090415584808207,0.0181820916677961,0.510490653867731
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48071,-0.0103674878742978,0.0127628274896645,-0.0353826297540402,0.0146476540054446,0.416616770557076
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48071,0.00317142365379229,0.0125189080340661,-0.0213656360929773,0.0277084834005619,0.800014884392214
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48071,-0.00442912389795889,0.00697442833087667,-0.0180990034264772,0.00924075563055937,0.525400724197276
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30746,0.00796131906549207,0.0270666630042534,-0.0450893404228446,0.0610119785538288,0.768662579182206
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30746,0.00534073504075595,0.0177708615937999,-0.0294901536830919,0.0401716237646038,0.763780353394885
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30746,-0.00387354438595125,0.022425025282196,-0.0478265939390553,0.0400795051671528,0.862866770042764
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30746,-0.00226379259003778,0.0201366602216136,-0.0417316466244005,0.0372040614443249,0.910492831657088
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48061,-0.00400357508395153,0.0190898494180299,-0.0414196799432901,0.033412529775387,0.833885903961884
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48061,0.0482747157327368,0.0338721990613773,-0.0181147944275628,0.114664225893036,0.154112124314856
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48061,0.0393680096964277,0.0549966564848431,-0.0684254370138648,0.14716145640672,0.474106177919078
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48061,0.0119206921950921,0.0518293245048437,-0.0896647838344015,0.113506168224586,0.818094548570956
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48061,-0.0125974866711657,0.0158974890556335,-0.0437565652202072,0.0185615918778759,0.428123842680512
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48061,0.0136932984168117,0.0229753954294284,-0.0313384766248679,0.0587250734584913,0.551182023801087
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48061,-0.00663900530810847,0.0112842377038198,-0.0287561112075953,0.0154781005913784,0.556307535718115
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32575,0.0271816462429242,0.017180443526298,-0.00649202306861975,0.0608553155544682,0.113659477490452
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32575,-0.00811662912512819,0.0195508423557667,-0.046436280142431,0.0302030218921746,0.678039434666977
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32575,-0.0384808873521602,0.0255797628656892,-0.088617222568911,0.0116554478645907,0.132530440563129
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32575,0.00268016471459177,0.00887917720489323,-0.014723022606999,0.0200833520361825,0.762775421774965
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35583,-0.00186307484507699,0.00891965819598564,-0.0193456049092088,0.0156194552190549,0.834551284808302
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35583,0.0123388517418517,0.00777830993356444,-0.00290663572793458,0.027584339211638,0.112696217718653
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35583,-0.0012920653153896,0.00731238738677176,-0.0156243445934622,0.013040213962683,0.859750858113685
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35583,-0.00908401701232849,0.0174948764819839,-0.043373974917017,0.02520594089236,0.603604614769876
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35583,-0.0166826041026048,0.0104306009735949,-0.0371265820108509,0.0037613738056413,0.109762243317022
CCND2,G1/S-specific cyclin-D2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35583,-0.0281036263309103,0.0121821191066701,-0.0519805797799836,-0.00422667288183697,0.021075476590192
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48071,-0.00497008246716045,0.0170667922583894,-0.0384209952936038,0.0284808303592828,0.770890498717251
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48071,-0.000882367285995565,0.0109199311591276,-0.0222854323578856,0.0205206977858945,0.935599009082969
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48071,-0.0210283896140998,0.0443362058800206,-0.10792735313894,0.0658705739107404,0.635294763830817
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48071,-0.0111279164898846,0.0107451870670312,-0.0321884831412656,0.0099326501614965,0.300390674594194
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48071,0.00847060891011571,0.0128701767037722,-0.0167549374292778,0.0336961552495092,0.51044306690135
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48071,0.000425398193748042,0.0144277694959656,-0.0278530300183445,0.0287038264058406,0.976478284840051
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48071,-3.66819484357122e-05,0.00515487474737536,-0.0101402364532914,0.01006687255642,0.994322383191218
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28200,0.00961015286885321,0.0175529890038361,-0.0247937055786655,0.0440140113163719,0.584072111097757
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28200,0.00633040455831463,0.0236017450893847,-0.0399290158168794,0.0525898249335087,0.788546547918201
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28200,0.0143828510774196,0.0155165375002257,-0.0160295624230228,0.0447952645778619,0.354018968071462
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28200,-0.0320497763854729,0.0139404211833997,-0.0593730019049364,-0.00472655086600947,0.021556627537337
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48176,0.00440513952499193,0.00588458206695275,-0.00712864132623546,0.0159389203762193,0.454111758352606
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48176,0.0103684428167361,0.0158318005747704,-0.0206618863098138,0.041398771943286,0.512530493195083
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48176,-0.00536947213260915,0.0057530261530094,-0.0166454033925076,0.00590645912728928,0.350659087979342
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48176,-0.0119732448816575,0.00573368924051193,-0.0232112757930609,-0.000735213970254158,0.0367879960308598
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48176,0.00689073862618224,0.00826573866343038,-0.0093101091541413,0.0230915864065058,0.404486253256672
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48176,-0.00419677754541608,0.00731657206096252,-0.0185372587849026,0.0101437036940705,0.566244706601374
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48176,-0.0116773710598782,0.00614479642461632,-0.0237211720521262,0.000366429932369761,0.0573970270206787
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48176,0.0094932563054491,0.01653547877158,-0.0229162820868478,0.041902794697746,0.565895839374004
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40806,0.00215605389468403,0.00607608575185637,-0.00975307417895445,0.0140651819683225,0.722712108934638
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40806,-0.00662902435353358,0.00672352496534179,-0.0198071332856035,0.00654908457853633,0.324174796357984
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40806,0.0108571061164274,0.00674926467014397,-0.00237145263705475,0.0240856648699096,0.107715389962822
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40806,-0.00681550929946526,0.00859073594404689,-0.0236533517497972,0.0100223331508666,0.427582125131909
CCND2,G1/S-specific cyclin-D2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40806,-0.0136800682563532,0.00611597938934158,-0.0256673878594627,-0.00169274865324367,0.0253144893260588
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47969,-0.0127272768562744,0.00618908040072988,-0.0248578744417049,-0.000596679270843815,0.0397541773344109
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47969,0.00500174794451442,0.00499653300486199,-0.00479145674501509,0.0147949526340439,0.31681597593388
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47969,0.00181524415538412,0.00545828421541182,-0.00888299290682305,0.0125134812175913,0.739464266546096
CCND2,G1/S-specific cyclin-D2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47969,0.0113671759767721,0.0120310812169794,-0.0122137432085076,0.0349480951620518,0.344761767052715
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47980,-0.00594689117905839,0.00564131065604386,-0.0170038600649044,0.00511007770678758,0.291816670175258
CCND2,G1/S-specific cyclin-D2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47980,-0.000627870994525753,0.0102019010340248,-0.0206235970212144,0.0193678550321629,0.950926090914729
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48071,0.00244454534439718,0.00538628760492775,-0.00811257836126122,0.0130016690500556,0.649943807637125
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48071,-0.00120519653770869,0.00611445002560291,-0.0131895185878904,0.010779125512473,0.843746060154844
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48071,-6.97669281792157e-05,0.00796412255925722,-0.0156794471443234,0.0155399132879649,0.993010572948128
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48071,-0.00132357658069986,0.0116060964573759,-0.0240715256371567,0.021424372475757,0.909205869772769
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48071,0.000345370850519253,0.0119108328852012,-0.0229998616044751,0.0236906033055136,0.976867735160202
CCND2,G1/S-specific cyclin-D2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48071,0.00952928433328383,0.0154519807469006,-0.0207565979306414,0.0398151665972091,0.537436524256366
CCND2,G1/S-specific cyclin-D2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37827,0.000599419820513306,0.00366160894038265,-0.00657733370263669,0.00777617334366331,0.869966686998154
CCND2,G1/S-specific cyclin-D2,Physical activities,X864.Number of days or week walked 10+ minutes,47634,0.0228547594937364,0.0320089815961493,-0.0398828444347162,0.085592363422189,0.475227673659673
CCND2,G1/S-specific cyclin-D2,Physical activities,X874.Duration of walks,44121,0.00557920062847562,0.00275322190073695,0.000182885703031198,0.01097551555392,0.0427346086490975
CCND2,G1/S-specific cyclin-D2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46704,0.0542736594767705,0.0308989718686543,-0.00628832538579191,0.114835644339333,0.0790189524447465
CCND2,G1/S-specific cyclin-D2,Physical activities,X894.Duration of moderate activity,41434,0.0411179092652267,0.0379789559862315,-0.0333208444677871,0.115556662998241,0.278979264997397
CCND2,G1/S-specific cyclin-D2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29464,0.0259826883254542,0.00584887642538075,0.0145188905317079,0.0374464861192004,9.09026061890701e-06
CCND2,G1/S-specific cyclin-D2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46729,0.0634912306936444,0.0315890415787928,0.00157670919921047,0.125405752188078,0.0444524165532431
CCND2,G1/S-specific cyclin-D2,Physical activities,X914.Duration of vigorous activity,36166,0.00198825339044098,0.00375883076783596,-0.00537905491451751,0.00935556169539947,0.596846493334736
